19
Views
12
CrossRef citations to date
0
Altmetric
Research Article

Chemically Induced Renal Papillary Necrosis and Upper Urothelial Carcinoma. Part 2

, &
Pages 331-439 | Published online: 26 Sep 2008

References

  • Toxicology of the Kidney, J. B. Hook. Raven Press, New York 1981
  • Nephrotoxicity and Ototoxicity of Drugs, J.P. Fillastre. Editions Insem, RouenFrance 1982
  • Mudge G. H., Duggin G. G. Symposium on drug effects on the kidney. Kidney Int. 1980; 18: 539
  • Nephrotoxic Mechanisms of Drugs and Environmental Toxins, G. A. Porter. Plenum Press, New York 1982
  • Nephrotoxicity: Assessment and Pathogenesis, P. H. Bach, F. W. Bonner, J. W. Bridges, E. A. Lock. John Wiley & Sons, ChichesterEngland 1982
  • International Symposium on Problems of Phenacatin Abuse, H. Haschek. Facta Publication, Wien 1973
  • Kincaid-Smith P. Symposium on analgesic nephropathy. Kidney Int. 1978; 13: 1
  • Consensus Conference. Analgesic kidney disease. JAMA 1984; 251: 3123
  • Shelley J. H. Phenacetin, through the looking glass. Clin. Pharmacol. Ther. 1967; 8: 427
  • Harrow B. R. Renal papillary necrosis: a critique of pathogenesis. J. Urol. 1967; 97: 203
  • Gault M. H., Rudwal T. C., Engles W. D., Dossetor J. B. Syndrome associated with the abuse of analgesics (review). Ann. Intern. Med. 1968; 68: 906
  • Abel J. A. Analgesic nephropathy – a review of the literature, 1967–1970. Clin. Pharmacol. Ther. 1971; 12: 583
  • Nanra R. S., Kincaid-Smith P. Chronic effects of analgesics on the kidney. Prog. Biochem. Pharmacol. 1972; 7: 285
  • Lee H. A., Davidson A. R., Burston J. Analgesic nephropathy in Wessex: a clinico-pathological survey. Clin. Nephrol. 1974; 2: 197
  • Murray T., Goldberg M. Analgesic abuse and renal disease. Annu. Rev. Med. 1975; 26: 537
  • Rosner I. Experimental analgesic nephropathy. CRC Crit. Rev. Toxicol. 1976; 4: 331
  • Stewart J. H., Gallery E. D. M. Analgesic abuse and kidney disease. Aust. N. Z. J. Med. 1976; 6: 498
  • Duggin G. G. Analgesic induced kidney disease. Aust. J. Pharm. Sci. 1977; 6: 44
  • Kerr D. N. S., Ward M. K. Renal disorder. Textbook of Adverse Drug Reactions, D. M. Davies. Oxford Medical Publications, Oxford 1977; 173
  • Burry A., Cross R., Axelsen R. Analgesic nephropathy and the renal concentrating mechanism. Pathol. Annu. 1977; 12: 1
  • Nanra R. S., Stuart-Taylor J., DeLeon A. H., White K. H. Analgesic nephropathy: etiology, clinical syndrome, and clinicopathologic correlations in Australia. Kidney Int. 1978; 13: 79
  • Shelley J. H. Pharmacological mechanism of analgesic nephropathy. Kidney Int. 1978; 13: 15
  • Cove-Smith J. R., Knapp M. S. Analgesic nephropathy: an important cause of chronic renal failure. Q. J. Med. 1978; 47: 49
  • Carro-Ciampi G. Phenacetin abuse: a review. Toxicology 1978; 10: 311
  • Hook J. B., McCormack K. M., Kluwe W. M. Biochemical mechanisms of nephrotoxicity. Rev. Biochem. Toxicol. 1979; 1: 53
  • Kincaid-Smith P. Analgesic nephropathy in Australia. Contrib. Nephrol. 1979; 16: 57
  • Duggin G. G. Mechanisms in the development of analgesic nephropathy. Kidney Int. 1980; 18: 553
  • Nanra R. S. Clinical and pathological aspects of analgesic nephropathy. Br. J. Clin. Pharmacol. 1980; 10: 359S
  • Laberke H. G. Drug-associated nephropathy. II. Tubulointerstitial lesions. Curr. Top. Pathol. 1980; 69: 183
  • Stygles V. G., Iuliucci J. D. Structural and functional alterations in the kidney following intake of non-steroidal anti-inflammatory analgesics. Toxicology of the Kidney, J. B. Hook. Raven Press, New York 1981; 151
  • Prescott L. F. Analgesic nephropathy: a reassessment of the role of phenacetin and other analgesics. Drugs 1982; 23: 75
  • Eknoyan G., Qunibi W. Y., Grissom R. T., Tuma S. N., Ayus J. C. Renal papillary necrosis: an update. Medicine 1982; 61: 55
  • Bach P. H., Bridges J. W. Chemical associated renal papillary necrosis. Nephrotoxicity: Assessment and Pathogenesis, P. H. Bach, F. W. Bonner, J. W. Bridges, E. A. Lock. John Wiley & Sons, ChichesterEngland 1982; 437
  • Molland E. A. Experimental renal papillary necrosis. Kidney Int. 1978; 13: 5
  • Prescott L. F. The nephrotoxicity and hepatotoxicity of antipyretic analgesics. Br. J. Clin. Pharmacol. 1979; 7: 453
  • Black D. The story of nephrology. J. R. Soc. Med. 1980; 73: 514
  • Oliver J. The antithesis of structure and function in renal activity. Bull. N. Y. Acad. Med. 1961; 37: 81
  • Renal Functions: Mechanisms Preserving Fluid and Solute Balance in Health, H. Valtin. Little, Brown, Boston 1973
  • Handbook of Physiology, Section 8, J. Orloff, R. W. Berliner. American Physiological Society, Washington, DC 1973
  • The Kidney, B. M. Brenner, F. C. Rector. W. B. Saunders, Philadelphia 1981; Vol. 1 and 2
  • Structural Basis of Renal Disease, E. Lovell-Becker. Hoeber Medical, New York 1968
  • Moffat D. B. The fine structure of the blood vessels of the renal medulla with particular reference to the control of the medullary circulation. J. Ultrastruct. Res. 1967; 19: 532
  • Moffat D. B. The Mammalian Kidney. Cambridge University Press, CambridgeEngland 1979
  • Moffat D. B. New ideas on the anatomy of the kidney. J. Clin. Pathol. 1981; 34: 1197
  • Moffat D. B. Morphology of the kidney in relation to nephrotoxicity–Portae Renales. Nephrotoxicity: Assessment and Pathogenesis, P. H. Bach, F. W. Bonner, J. W. Bridges, E. A. Lock. John Wiley & Sons, ChichesterEngland 1982; 10
  • Bohman S.O. The ultrastructure of the renal medulla and the interstitial cells. The Renal Papilla and Hypertension, A. K. Mandal, S.O. Bohman. Plenum Press, New York 1980; 7
  • Functional Ultrastructure of the Kidney, A. N. Maunsbach, T. S. Olsen, E. I. Christensen. Academic Press, London 1980
  • Bulger R. E., Dobyan D. C. Recent advances in renal morphology. Annu. Rev. Physiol. 1982; 44: 147
  • Kriz W. Structural organization of the renal medulla: comparative and functional aspects. Am. J. Physiol. 1981; 241: R3
  • Jamison R. L., Kriz W. Urinary Concentrating Mechanism: Structure and Function. Oxford University Press, OxfordEngland 1982
  • Schmidt-Nielsen B., Graves B. Changes in fluid compartments in hamster renal papilla due to peristalsis in the pelvic wall. Kidney Int. 1982; 22: 613
  • Beeuwkes R. The vascular organization of the kidney. Annu. Rev. Physiol. 1980; 42: 531
  • Pearson R. M. Methods for the assessment of the effects of drugs on renal blood flow. Br. J. Clin. Pharmacol. 1979; 7: 129
  • Grunfeld J. P., Raphael J. C., Bankir W., Kleinknecht D., Barger A. C. Intrarenal distribution of blood flow. Adv. Nephrol. 1971; 1: 125
  • Aukland K. Methods for measuring renal blood flow: total flow and regional distribution. Annu. Rev. Physiol. 1980; 42: 543
  • Daniel P. M., Peabody C. N., Prichard M. M. L. Observations of the circulation through the cortex and the medulla of the kidney. Q. J. Exp. Physiol. 1951; 36: 199
  • Kramer K., Deetjen P., Thurau K. Hämodynamik des Nierenmarks. I. Capilläre Passagezeit, Blutvolumen, Durchblutung, Gewebhämatokrit und O2-Verbrauch des Nierenmarks in situ. Arch. Ges. Physiol. 1960; 270: 251
  • Lilienfield L. S., Maganzini H. C., Bauer M. H. Blood flow in the renal medulla. Circ. Res. 1961; 9: 614
  • Thorbum G. D., Kopald H. H., Herd J. A., Hollenberg M., O'Morchoe C. C. C., Barger A. C. Intrarenal distribution of nutrient blood flow determined with85krypton in the unanesthetized dog. Circ. Res. 1963; 13: 290
  • Grandchamp A., Ayer G., Scherrer J. R., Truniger B. Intrarenal haemodynamics of the rat kidney determined by the xenon washout technique. Nephron 1971; 8: 33
  • Lameire N. H., Lifschitz M. D., Stein J. H. Heterogeneity of nephron function. Annu. Rev. Physiol. 1977; 39: 159
  • Stein J. H., Ferris T. F., Huprich J. E., Smith T. C., Osgood R. W. Effect of renal vasodilation on the distribution of cortical blood flow in the kidney of the dog. J. Clin. Invest. 1971; 50: 1429
  • Rosivall L., Posch E., Simon G., Laszlo E., Harsing L. Intrarenal distribution of renal blood flow in the rat. Acta Physiol. Acad. Sci. Hung. 1979; 53: 387
  • Stern M. D., Bowen P. D., Parma R., Osgood R. W., Bowman R. L., Stein J. H. Measurement of renal cortical and medullary blood flow by laser-Doppler spectroscopy in the rat. Am. J. Physiol. 1979; 236: F80
  • Thurau K. Renal hemodynamics. Am. J. Med. 1964; 36: 698
  • Schurer J. W., Fleuren G.J., Hoedemaeker P. J., Molenaar I. A macromolecular model of the glomerular basement membrane. Functional Ultrastructure of the Kidney, A. B. Maunsbach, T. S. Olsen, E. I. Christensen. Academic Press, London 1980; 105
  • Oken D. E., Landwehr D. M., Kirschbaum B. B. The haemodynamic basis for experimental acute renal failure. Nephrotoxicity: Assessment and Pathogenesis, P. H. Bach, F. W. Bonner, J. W. Bridges, E. A. Lock. John Wiley & Sons, ChichesterEngland 1982; 169
  • Wolgast M., Persson E., Schnermann J., Ulfendahl H., Wunderlich P. Colloid osmotic pressure of the subcapsular interstitial fluid of rat kidneys during hydropenia and volume expansion. Pfluegers Arch. 1973; 340: 123
  • Galaske R. G., Van Liew J. B., Feld L. G. Urinary protein excretion in the rat: strain and age dependence. Contrib. Nephrol. 1980; 19: 71
  • Schenk E. A., Schwartz R. H., Lewis R. A. Tamm-Horsfall mucoprotein. I. Localization in the kidney. Lab. Invest. 1971; 25: 92
  • StDawnay A. J. B., Cattell W. Tamm-Horsfall glycoprotein – a review. Nephron, in press
  • Ransley P. G., Risdon R. A. The pathogenesis of reflux nephropathy. Contrib. Nephrol. 1979; 16: 90
  • Earley L. E., Friedler R. M. Observations on the mechanism of decreased tubular reabsorbtion of sodium and water during saline loading. J. Clin. Invest. 1964; 43: 1928
  • Earley L. E., Friedler R. M. Changes in renal blood flow and possibly the intra-renal distribution of blood during natriuresis accompanying saline loading in the dog. J. Clin. Invest. 1965; 44: 929
  • Chuang E. L., Reineck H. J., Osgood R. W., Kunau R. T., Stein J. H. Studies on the mechanism of reduced urinary osmolality after exposure of renal papilla. J. Clin. Invest. 1978; 61: 633
  • Bayle F., Eloy L., Trinh-Trang-Tan M.M., Grunfeld J.P., Bankir L. Papillary plasma flow in rats. I. Relation to urine osmolality in normal and Brattleboro rats with hereditary diabetes insipidus. Pfluegers Arch. 1982; 394: 211
  • Eloy L., Grunfeld J.P., Bayle F., Bankir L., Ramos-Frendo B., Trinh-Trang-Tan M.M. Papillary plasma flow in rats. II. Hormonal control. Pfluegers Arch. 1983; 398: 253
  • Abrahams C. The ultrastructure of the interstitial tissue of the renal papilla of the rat. S. Afr. J. Med. Sci. 1964; 29: 17
  • Osvaldo L., Latta H. Interstitial cells of the renal medulla. J. Ultrastruct. Res. 1966; 15: 589
  • The Renal Papilla and Hypertension, A. K. Mandal, S.O. Bohman. Plenum Press, New York 1980
  • Muirhead E. E., Pitcock J. A. Evidence on involvement of the renal papilla in hypertension. The Renal Papilla and Hypertension, A. K. Mandal, S.O. Bohman. Plenum Press, New York 1980; 35
  • Guder W. G., Ross B. D. Biochemical aspect of renal function. Int. J. Biochem. 1980; 12: 1
  • Cohen J. J. Is the function of the renal papilla coupled exclusively to an anaerobic pattern of metabolism?. Am. J. Physiol. 1979; 236: F423
  • Kean E. L., Adams P. H., Winters R. W., Davies R. E. Energy metabolism of the renal medulla. Biochim. Biophys. Acta 1961; 54: 474
  • Kean E. L., Adams P. H., Conrad-Davies H., Winters R. W., Davies R. E. Oxygen consumption and respiratory pigments of mitochondria of the inner medulla of the dog kidney. Biochim. Biophys. Acta 1962; 64: 503
  • Lee J. B., Vance V. K., Cahill G. F. Metabolism of14C-labelled substrates by rabbit kidney cortex and medulla. Am. J. Physiol. 1962; 203: 27
  • Lee J. B., Vance V. K., Cahill G. F. Effect of osmolality on glucose metabolism in rabbit kidney cortex and medulla in vitro. Am. J. Physiol. 1964; 207: 473
  • Balasubramanian A., Ramakrishnan S. Effect of aspirin and prostaglandins on the carbohydrate metabolism in albino rats: glucose oxidation through different pathways and glycolytic enzymes. Indian J. Med. Res. 1980; 71: 416
  • Darnton S. J. Glycogen metabolism in rabbit kidney under differing physiological states. Q. J. Exp. Physiol. 1967; 52: 392
  • Darnton S. J. The conversion of injected glucose into renal glycogen and mucopolysaccharides. An autoradiographic study of rabbits in various states of hydration. Z. Zellforsch. 1969; 102: 273
  • Darnton S. J. Carbohydrate Metabolism in the Renal Papilla of Small Mammals Under Various States of Hydration. Ph.D. thesis, University of London, LondonEngland1969
  • Cohen J. J., Kamm D. E. Renal metabolism: relation to renal function. The Kidney, B. M. Brenner, F. C. Rector. W. B. Saunders, Philadelphia 1981; 144
  • Bonner F. W., Bach P. H., Dobrota M. The biochemistry of the kidney. Nephroroxicity: Pathogenesis and Assessment, P. H. Bach, F. W. Bonner, J. W. Bridges, E. A. Lock. John Wiley & Sons, ChichesterEngland 1982; 27
  • Morgan T. E., Ticker D. O., Hanahan D. J. Phospholipid metabolism in the kidney. I. Isolation and identification of lipids of rabbit kidney. Arch. Biochem. Biophys. 1963; 103: 54
  • Gold M. An investigation of lipid metabolism of dog kidney medulla and cortex. Lipids 1970; 5: 293
  • Hohenegger M., Wittmann G., Dahlheim H. Oxidation of fatty-acids by different zones of rat-kidney. Pfluegers Arch. 1973; 341: 105
  • Cohn J. J., Wittmann E. Renal utilization and excretion of α-ketoglutarate in dog: effect of alkalosis. Am. J. Physiol. 1963; 204: 795
  • Barac-Nieto M., Cohn J. J. Nonesterified fatty acid uptake by kidney: effect of probenecid and chlorothiazide. Am. J. Physiol. 1968; 215: 98
  • Tinker D. O., Hanahan D. J. Phospholipid metabolism in kidney. III. Biochemistry of radioactive precursors in rabbit renal cortex slices. Biochemistry 1966; 5: 423
  • Bojesen I. Quantitative and qualitative analyses of isolated lipid droplets from interstitial cells in renal papillae from various species. Lipids 1974; 9: 835
  • Bojesen I. N. Fatty acid composition and depot function of lipid droplet triacylglycrols in renomedullary interstitial cells. The Renal Papilla and Hypertension, A. K. Mandal, S.O. Boham. Plenum Press, New York 1980; 121
  • Bojesen I., Bojesen E., Capito K. In vitro and in vivo synthesis of long-chain fatty acids from [1-14C]acetate in the renal papillae of rats. Biochim. Biophys. Acta 1976; 424: 8
  • Bojesen I. N. In vitro and in vivo lipgenesis of the rat renal papillae in rats. Biochim. Biophys. Acta 1980; 619: 308
  • Bojesen I. N. The influence of urea on lipogenesis in renal papillae in rats. Lipids 1980; 15: 519
  • Limas C., Limas C. J. Phospholipid metabolism in the rat renal inner medulla. Biochim. Biophys. Acta 1983; 753: 314
  • Ullrich K. J. Glycerylphosphorylcholinumsatz und Glyceryphosphorylcholindiesterase in der Saugetier-Niere. Biochem. Z. 1959; 331: 98
  • Van den Bosch H. Phosphoglyceride metabolism. Annu. Rev. Biochem. 1974; 43: 243
  • Bojesen I. N. The physiological role of renomedullary lipogenesis. Biochemistry of Kidney Functions, F. Morel. Elsevier, Amsterdam 1982; 103, 21st INSERM Symp.
  • Florendo N. T., Pitcock J. A., Muirhead E. E. Cyclic 3′,5′-mucleotide phosphodiesterase; cytochemical localization in rat renomedullary interstitial cells. Phosphodiesterase in rat renal medulla. J. Histochem. Cytochem. 1978; 26: 441
  • Sun F. F., Taylor B. M., McGuire J. C., Wong P. Y. K. Metabolism of prostaglandins in the kidney. Kidney Int. 1981; 19: 760
  • Frolich J. C., Walker L. A. Determination, source, metabolism, and functional role of renal prostaglandins. Clin. Exp. Hypertension 1980; 2: 709
  • Dunn M. J., Hood V. L. Prostaglandins and the kidney. Am. J. Physiol. 1977; 223: F169
  • Dunn M. J., Zambraski E. J. Renal effects of drugs that inhibit prostaglandin synthesis. Kidney Int. 1980; 18: 609
  • Morrison A. R. Prostaglandins and the kidney. Am. J. Med. 1980; 69: 171
  • Weber P. C., Siess W. Influence of renal prostaglandins on renin release. The Renal Papilla and Hypertension, A. K. Mandal, S.O. Bohman. Plenum Press, New York 1980; 209
  • Zusman R. M. Prostaglandin E2 biosynthesis by renomedullary interstitial cells:in vitro studies and pathophysiological correlations. The Renal Papilla and Hypertension, A. K. Mandal, S.O. Bohman. Plenum Press, New York 1980; 187
  • Dunn M. J. Prostaglandins and Bartter's syndrome. Kidney Int. 1981; 19: 86
  • McGiff J. C. Prostaglandins, prostacyclin and thromboxanes. Annu. Rev. Pharmacol. Toxicol. 1981; 21: 479
  • Frolich J. C., Nies A. S., Schrier R. W. Prostaglandins and the kidney. Kidney Int. 1981; 19: 755
  • Okahara T., Imanishi M., Yamamoto K. Zonal heterogeneity of prostaglandin and thromboxane release in the dog kidney. Prostaglandins 1978; 25: 373
  • Hassid A., Dunn M. J. Microsomal prostaglandin biosynthesis of human kidney. J. Biol. Chem. 1980; 255: 2472
  • Reingold D. F., Watters K., Holmberg S., Needleman P. Differential biosynthesis of prostaglandins by hydronephrotic rabbit and cat kidneys. J. Pharmacol. Exp. Ther. 1981; 216: 510
  • Winokur T. S., Morrison A. R. Regional synthesis of monohydroxy eicosanoids by the kidney. J. Biol. Chem. 1981; 256: 10221
  • Van Praag D., Farber S. J. Biosynthesis of cyclooxygenase and lipoxygenase metabolites of arachidonic acid by rabbit renal microsomes. Prostaglandins Leuk. Med. 1983; 12: 29
  • Van Dorp D. Recent developments in the biosynthesis and the analyses of prostaglandins. Ann. N.Y. Acad. Sci. 1971; 180: 181
  • Hirafuji M., Satoh S., Ogura Y. Sex difference in stimulatory actions of cofactors on prostaglandin synthetase in microsomes from rat kidney medulla. Biochem. Pharmacol. 1980; 29: 2635
  • Lee J. B., Crowshaw K., Takman B. H., Attrep K. A. The indentification of prostaglandins E2, F2α and A2 from rabbit kidney medulla. Biochem. J. 1967; 105: 1251
  • Janszen F. H. A., Nugteren D. H. A histochemical study of the prostaglandin biosynthesis in the urinary system of rabbit, guinea pig, goldenhamster and rat. Adv. Biosci. 1973; 9: 287
  • Bohman S-. O., Maunsbach A. B. Ultrastructural and biochemical properties of subcellular fractions from rat renal medulla. J. Ultrastruct. Res. 1972; 38: 225
  • Smith W. L., Wilkin G. P. Immunochemistry of prostaglandin endoperoxide-forming cyclooxygenase: the detection of the cyclooxygenases in rat, rabbit and guinea pig kidneys by immunofluorescence. Prostaglandins 1977; 13: 873
  • Mori Y., Mine M. The localization of prostaglandins in the rabbit kidneys demonstrated with indirect immunofluorescence. Biomed. Res. 1981; 2: 281
  • Rosenkranz B., Kitajima W., Frolich J. C. Prostacyclin – a renal hormone. Biochemistry of Kidney Functions, F. Morel. Elsevier, Amsterdam 1982; 139, 21st INSERM Symp.
  • Muirhead E. E., Germain G., Leach B. E., Pitcock J. A., Stephenson P., Brooks B., Brosius W. L., Daniels E. G., Hinman J. W. Production of renomedullary prostaglandins by renomedullary interstitial cells grown in tissue culture. Circ. Res. 1972; 31: 161
  • Zusman R. M., Keiser H. R. Prostaglandin E2 biosynthesis by rabbit renomedullary interstitial cells in tissue culture. J. Biol. Chem. 1977; 252: 2069
  • Zusman R. M., Keiser H. R. Prostaglandin biosynthesis by rabbit renomedullary interstitial cells in tissue culture: stimulation by angiotensin II, bradykinin and arginine vasopressin. J. Clin. Invest. 1977; 60: 215
  • Mathews J., DuCharme D. W., McCandlis M. Morphology of cultured renomedullary interstitial cells. Micron. 1979; 10: 185
  • Kuroda M., Ueno H., Sakato S., Funaki N., Takeda R. A unique affinity and adaptation of renomedullary interstitial cells for hypertonic medium. Prostaglandins 1979; 18: 209
  • Sraer J., Ardaillou N., Sraer J.D., Ardaillou R. In vitro prostaglandin synthesis by human glomeruli and papillae. Prostaglandins 1982; 23: 855
  • Grenier F. C., Rollins T. E., Smith W. L. Kinin-induced prostaglandin synthesis by renal papillary collecting tubule cells in culture. Am. J. Physiol. 1981; 241: F94
  • Grenier F. C., Smith W. L. Formation of 6-keto-PGF1α by collecting tubule cells isolated from rabbit renal papillae. Prostaglandins 1978; 16: 759
  • Powell W. S. Distribution of prostaglandin w-hydroxylases in different tissues. Prostaglandins 1980; 19: 701
  • Anggard E., Oliw E. Formation and metabolism of prostaglandins in the kidney. Kidney Int. 1981; 19: 771
  • Horrobin D. F. The regulation of prostaglandin biosynthesis: negative feedback mechanisms and the selective control of formulation of 1 and 2 series prostaglandin: relevance to inflammation and immunity. Med. Hypotheses 1980; 6: 687
  • Tannenbaum J., Sweetman B. J., Nies A. S., Aulsebrook K., Oates J. A. The effect of glucose on the synthesis of prostaglandins by the renal papilla of the rat in vitro. Prostaglandins 1979; 17: 337
  • Craven P. A., Studer R. K., De Rubertis F. R. Renal inner medullary prostaglandin synthesis: a calcium-calmodulin-dependent process suppressed by urea. J. Clin. Invest. 1981; 68: 722
  • Roman R. J., Lechene C. Prostaglandin E2 and E2α reduces urea reabsorption from the rat collecting duct. Am. J. Physiol. 1981; 241: F53
  • Attallah A., Stahl R. Inhibition of renal PGE2 biosynthesis in vivo: regional differences. Prostaglandins 1980; 19: 649
  • Suzuki S., Shapiro R., Mulrow P. J., Tan S. Y. Urinary prostaglandin E2 excretion in chronic renal disease. Prostaglandins Med. 1980; 4: 377
  • Brown W. W., Zenser T. V., Davis B. B. Prostaglandin E2 production by rabbit urinary bladder. Am. J. Physiol. 1980; 239: F452
  • Larsson C., Weber P., Anggard E. Arachidonic acid increases and indomethacin decreases plasma renin activity in the rabbit. Eur. J. Pharmacol. 1974; 28: 391
  • Franco-Saenz R., Suzuki S., Tan S. Y. Prostaglandins and renin production: a review. Prostaglandins 1980; 20: 1131
  • Hackenthal E., Schwertschlag U., Seyberth H. W. Prostaglandins and renin release studies in the isolated perfused rat kidney. Prog. Biochem. Pharmacol. 1980; 17: 98
  • Lee J. B. Prostaglandins and the renin-angiotensin axis. Clin. Nephrol. 1980; 14: 159
  • Weber P. C. Renal prostaglandins, kidney function and essential hypertension. Contrib. Nephrol. 1980; 23: 83
  • Baer P. G. The contribution of prostaglandins to renal blood flow maintenance is determined by the level of activity of the renin-angiotensin system. Life Sci. 1981; 28: 587
  • Weber P. C., Siess W. Interactions of renal prostaglandins with the renin-angiotensin system. Pharmacol. Ther. 1982; 15: 321
  • Fitz Gerald G.A., Hossmann V., Hummerich W., Konrads A. The renin-kallikrein-prostaglandin system: plasma active and inactive renin and urinary kallikrein during prostacyclin infusion in man. Prostaglandins Med. 1980; 5: 445
  • Margolius H. S. The kallikrein-kinin system, renal function and hypertensive diseases. Prog. Biochem. Pharmacol. 1980; 17: 116
  • Rockel A., Heidland A. Kallikrein-kinin system and hypertension. Contrib. Nephrol. 1980; 23: 105
  • Blair-West J. R., Bobik A., Brook A. H., Esler M. D., Gibson A., Morris M., McKinley M. J., Pullan P. T. Renin, ADH and the kidney: a congeries of conundrums. Prog. Biochem. Pharmacol. 1980; 17: 20
  • Rosenkranz B., Kitajima W., Frolich J. C. Relevance of urinary 6-keto-prostaglandin F1α determination. Kidney Int. 1981; 19: 755
  • Neumayer H.H., Wagner K., Schultze G., Laubner P., Maiga M. K., Molzahn M. Influence of prostaglandins A1, E1, E2α on renal blood flow and plasma renin activity. Renal Physiol. 1982; 5: 57
  • Blasingham M. C., Shade R. E., Share L., Nasjletti A. The effect of meclofenamate on renal blood flow in the unanesthetized dog: relation to renal prostaglandins and sodium balance. J. Pharmacol. Exp. Ther. 1980; 214: 1
  • Dunn M. J., Greely H. P., Valtin H., Kinter L. B., Beeuwkes R., III. Renal excretion of prostaglandins E2 and F2α in diabetes insipidus rats. Am. J. Physiol. 1978; 235: E624
  • Bankir L., Trinh Trang Tan M.M., Nivez M.P., Sraer J., Ardaillou R. Altered PGE2 production by glomeruli and papilla of rats with hereditary diabetes insipidus. Prostaglandins 1980; 20: 349
  • Stoff J. S., Rosa R. M., Silva P., Epstein F. H. Indomethacin impairs water diuresis in the DI rat: role of prostaglandins independent of ADH. Am. J. Physiol. 1981; 241: F231
  • Ray C., Morgan T. The effect of prostaglandin E2 and ADH on diffusional water permeability in the collecting duct of an isolated rat papilla. Pfluegers Arch. 1981; 392: 51
  • Walker R. M., Brown R. S., Stoff J. S. Role of renal prostaglandins during antidiuresis and water diuresis in man. Kidney Int. 1981; 21: 365
  • Zalc B., Monge M., Baumann M. Immunohistochemical localization of sulfatide in kidney and central nervous system. Biol. Cell. 1980; 36: A10
  • McQueen E. G. Nature of urinary casts. J. Clin. Pathol. 1962; 15: 367
  • Anders D., Thoenes W. Fine structural evidence of Tamm-Horsfall protein as a constituent of tubular casts in the nephrotic syndrome. Contrib. Nephrol. 1981; 24: 42
  • Cotran R. S. Pathogenetic mechanisms in the progression of reflux nephropathy: the roles of glomerulosclerosis and extravasation of Tamm-Horsfall protein. Proc. 8th Int. Congr. Nephrol., Athens, 1981; 864
  • Hoyer J. R., Ishidate T. Pathophysiology of Tamm-Horsfall protein in tubulointerstitial nephritis. Proc. 8th Int. Congr. Nephrol., Athens, 1981; 783
  • Wenk R. E., Bhagavan B. S., Rudert J. Tamm-Horsfall uromucoprotein and the pathogenesis of casts, reflux nephropathy and nephritides. Pathobiol. Ann. 1981; 11: 229
  • Powell C. J., Bach P. H. 1982, unpublished data
  • Richet G. The mechanism of action of some loop-acting diuretics – role of a binding to Tamm-Horsfall protein. Clin. Nephrol. 1983; 19: S42
  • Asscher A. W. Urinary tract infection. J. R. Coll. Physicians London 1981; 15: 232
  • Orskov J., Ferencz A., Orskov F. Tamm-Horsfall protein or uromucoid is the normal urinary slime that traps Type 1 fimbriatedEscherichia coli. Lancet 1980; 1: 887
  • Friedman J., Hoyer J. R., Seiler M. W. Formation and clearance of tubulointerstitial immune complexes in kidneys of rats immunized with heterologous antisera to Tamm-Horsfall protein. Kidney Int. 1982; 21: 575
  • Rosenzweig L. J., Kanwar Y. S. Removal of sulfated (heparan sulfate) or nonsulfated (hyaluronic acid) glycosaminoglycans results in increased permeability of the glomerular basement membrane to125I-bovine serum albumin. Lab. Invest. 1982; 47: 177
  • Moffat D. B., Creasey M. The fine structure of the intraarterial cushions at the origins of the juxtamedullary afferent arterioles in the rat kidney. J. Anat. 1971; 110: 409
  • Lubec G. Renal immunology. Contrib. Nephrol. 1983; 35: 1
  • Kennedy J. F. Proteoglycans – Biological and Chemical Aspects in Human Life. Elsevier, Amsterdam 1979
  • Cell Biology of Extracellular Matrix, E. D. Hay. Plenum Press, New York 1982
  • Glycosaminoglycans and Proteoglycans in Physiological and Pathological Processes of Body Systems, R. S. Varma, R. Varma. S. Karger, Basel 1982
  • Extracellular Matrix, S. Hawkes, J. L. Wang. Academic Press, New York 1982
  • Dietrich C. P., Sampaio L. O., Toledo O. M. S. Characteristic distribution of sulfated mucopolysaccharides in different tissues and in their respective mitochondria. Biochem. Biophys. Res. Commun. 1976; 71: 1
  • Toledo O. M. S., Dietrich C. P. Tissue specific distribution of sulfated mucopolysaccharides in mammals. Biochim. Biophys. Acta 1977; 498: 114
  • Suzuki S., Suzuki S., Nakamura N., Koizumi T. The heterogeneity of dematan sulfate and heparan sulfate in rat liver and a shift in the glycosaminoglycan contents in carbon tetrachloride damaged liver. Biochim. Biophys. Acta 1976; 428: 166
  • Ng Kwai Hang K. F., Anastassiadis P. A. Glycosaminoglycans of tissues of the domestic fowl. Can. J. Biochem. 1980; 58: 319
  • Ng Kwai Hang K. F., Anastassiadis P. A. Studies on thein vivo uptake and incorporation of I-14C-labeled D-hexosamines in tissues, mucopolysaccharide-peptide complexes, and glycosaminoglycans of the domestic fowl. Can. J. Biochem. 1980; 58: 325
  • Allalouf D., Ber A., Sharon N. Acid mucopolysaccharides in rat kidneys. Biochim. Biophys. Acta 1954; 83: 278
  • Barry D. N., Bowness J. M. Identification and turnover of glycosaminoglycans in rat kidneys. Can. J. Biochem. 1975; 53: 713
  • Lis D., Monis B. Glycosaminoglycans in separated tubules of the guinea-pig and rat kidney medulla. Experientia 1978; 34: 693
  • Kanwar Y. S., Farquhar M. G. Presence of heparan sulfate in the glomerular basement membrane. Proc. Natl. Acad. Sci. U.S.A. 1979; 76: 1303
  • Hassell J. R., Robey P. G., Barrach H.J., Wilczek J., Rennard S. I., Martin G. R. Isolation of a heparan sulfate-containing proteoglycan from basement membrane. Proc. Natl. Acad. Sci. U.S.A. 1980; 77: 4494
  • Farber S. J., Cohen G. L., Kastor J. A. The chemical and metabolic properties of acid mucopolysaccharides of renal papillae. Trans. Assoc. Am. Physicians 1962; 75: 154
  • Farber S. J., Van Praag D. Composition of glycosaminoglycans (mucopolysaccharides) in rabbit renal papilla. Biochim. Biophys. Acta 1970; 208: 219
  • Dicker S. E., Franklin C. S. The isolation of hyaluronic acid and chondroitin sulphate from kidneys and their reaction with urinary hyaluronidase. J. Physiol. (London) 1966; 186: 110
  • Castor C. W., Green J. A. Regional distribution of acid mucopolysaccharides in the kidney. J. Clin. Invest. 1968; 47: 2125
  • Murata K. Polydisperse distribution of acidic glycosaminoglycans in bovine kidney tissue. Connect. Tissue Res. 1976; 4: 131
  • Constantopoulos G., Louie M., Dekaban A. S. Acid mucopolysaccharides (glycosaminoglycans) in normal human kidneys and in kidneys of patients with mucopolysaccaridoses. Biochem. Med. 1973; 7: 376
  • Murata K. Differences in acidic glycosaminoglycans in cortical and medullary tissue in human kidney. Renal Physiol. 1979/1980; 2: 346
  • Norhagen A., Odeblad E. A study on the uptake of radioactive sulfate in the kidney. Acta Pathol. Microbiol. Scand. 1955; 36: 224
  • Monis B., Longley J. B. Mucins in the epithelium of renal collecting tubules. Nature (London) 1955; 176: 741
  • Mowry R. W., Morard J. C. The distribution of acid mucopolysaccharides in normal kidneys, as shown by the alcian blue-feulgen (AB-F) and alcian blue-periodic acid-schiff (AB-PAS) stains. Am. J. Pathol. 1957; 33: 620
  • Longley J. B., Burtner H. J., Monis B. Mucous substances of excretory organs: a comparative study. Ann. N.Y. Acad. Sci. 1963; 106: 493
  • Furusato M. Ultrastructure and histochemistry of the medullary interstitial matrix of rat kidney. Acta Pathol. Jpn. 1977; 27: 331
  • Murata K. Glycosaminoglycans of kidney: normal and pathological aspects. Glycosaminoglycans and Proteoglycans and Pathological Processes of Body Systems, R. S. Varma, R. Varma. S. Karger, Basel 1982; 135
  • Jacobson A., Grieco A. J., Farber S. J. Hexosamine analysis of renal papillae in diuretic and antidiuretic rats. Proc. Soc. Exp. Biol. Med. 1964; 115: 1153
  • Allalouf D., Ber A. Distribution of acid mucopolysaccharides in rat kidneys and effect of unilateral nephrectomy. Med. Exp. 1969; 19: 129
  • Kresse H., Grossman A. Vergleichende untersuchung des Mucopolysaccharide und Kollagengehaltes in verschiedenen topographischen Zonen der niere von Ratte, Hund und Schwein. Z. Klin. Chem. Klin. Biochem. 1970; 8: 420
  • Inoue G., Sawada T., Fukunaga Y., Yoshikawa M. Levels of acid mucopolysaccharides in aging human kidneys. Gerontrologia 1970; 16: 261
  • Inoue G., Sawada T., Yoshikawa M. Age-related change in acid mucopolysaccharides level and water content in papillary region of human kidneys. Gerontologia 1973; 19: 73
  • Murata K., Horiuchi Y. Age-dependent distribution of acidic glycosaminoglycans in human tissue. Nephron 1978; 20: 111
  • Murata K., Ishikawa T., Ninomiya H. Age-dependent changes of chondroitin sulfate isomers in normal human urine. Biochem. Med. 1973; 8: 472
  • Wessler E. The nature of the non-ultrafilterable glycosaminoglycans of normal human urine. Biochem. J. 1971; 122: 373
  • Murata K. Acidic glycosaminoglycans in human kidney tissue. Clin. Chim. Acta 1975; 63: 157
  • Murata K., Horiuchi Y. Occurrence of an overall dermatan sulfate in kidney tissue. Renal Physiol. 1978; 1: 48
  • Szokol M., Soltesz M. B. Histochemical study on the oxidative enzymes of the interstitial cells of the renal medulla in rats. Acta Histochem. 1973; 46: 120
  • Pitcock J. A., Leach B. E., Rightsel W. A., Muirhead E. E. Proteoglycans of the rat renal papillary interstitium. Ultrastructural observations and synthesis by renomedullary interstitial cells. Fed. Proc. Fed. Am. Soc. Exp. Biol. 1978; 37: 633
  • Dorfman A. Proteoglycan biosynthesis. Cell Biology of Extracellular Matrix, E. D. Hay. Plenum Press, New York 1982; 115
  • Miller R. P., Husain M., Lohin S. Long acting cAMP analogues enhance sulfate incorporation into matrix proteoglycans and suppress cell division of fetal rat chondrocytes in monolayer culture. J. Cell Physiol. 1979; 100: 63
  • Miller R. P., Erickson-Lucas M. Divergent effects of long acting cyclic nucleotides and lysine vasopressin on the release of matrix sulfated proteoglycans into the medium of fetal rat chondrocytes in monolayer culture. J. Cell. Physiol. 1980; 104: 391
  • Edwards R. M., Jackson B. A., Dousa T. P. ADH-sensitive cAMP system in papillary collecting duct: effect of osmolality and PGE2. Am. J. Physiol. 1981; 240: F311
  • Valtin H. Sequestration of urea and nonurea solutes in renal tissue of rats with hereditary hypothalamic diabetes insipidus: effect of vasopressin and dehydration on the countercurrent mechanism. J. Clin. Invest. 1966; 45: 337
  • McAuliffe W. G. Histochemistry and ultrastructure of the interstitium of the renal papilla in rats with hereditary diabetes insipidus (Brattleboro strain). Am. J. Anat. 1980; 157: 17
  • McAuliffe W. G. The effect of antidiuretic hormone on the histochemistry and ultrastructure of the interstitium of the renal papilla in rats with hereditary diabetes insipidus (Brattleboro strain). Am. J. Anat., submitted
  • Beck T. R., Hassid A., Dunn M. J. The effect of arginine vasopressin and its analogs on the synthesis of prostaglandin E2 by rat renal medullary interstitial cells in culture. J. Pharmacol. Exp. Ther. 1980; 215: 15
  • Pietila K., Mollanen T., Nikkari T. Prostaglandins enhance the synthesis of glycosaminoglycan and inhibit the growth of rabbit aortic smooth muscle cells in culture. Artery 1980; 7: 509
  • Tjugum J., Norstrom A., Dennefors B. Influence of prostaglandin E2 on proteoglycan synthesis in the human ovarian follicle wall. Prostagladins 1983; 25: 71
  • Craven P. A., Briggs F., DeRubertis F. R. Calcium-dependent action of osmolality on adenosine 3′,5′-monophosphate accumulation in rat renal inner medulla. J. Clin. Invest. 1980; 65: 529
  • Jacobson B. Hyaluronic acid synthesis in rooster comb. Effect of testosterone on nucleotide sugar metabolism. Connect. Tissue Res. 1978; 5: 217
  • Uzuka M., Nakajima K., Ohta S., Mori Y. The mechanism of estrogen-induced increase in hyaluronic acid biosynthesis, with special reference to estrogen receptor in the mouse skin. Biochim. Biophys. Acta 1980; 627: 199
  • Shiller S. The effect of hormones on synthesis of the region linking chondroitin sulfate to protein. Biochim. Biophys. Acta 1976; 451: 457
  • Schiller S., Slover G. A., Dorfman A. Effect of the thyroid gland on metabolism of acid mucopolysaccharides in skin. Biochim. Biophys. Acta 1962; 58: 27
  • Smith T. J., Horwitz A. L., Refetoff S. The effect of thyroid hormone on glycosaminoglycan accumulation in human skin fibroblasts. Endocrinology 1981; 108: 2397
  • Smith T. J., Murata Y., Horwitz A. L., Philipson L., Refetoff S. Regulation of glycosaminoglycan synthesis by thyroid hormone in vitro. J. Clin. Invest. 1982; 70: 1066
  • Katz M. A. Interstitial space – the forgotten organ. Med. Hypotheses 1980; 6: 885
  • Bok S. W. The fundamental role of hyaluronidase in tissue. Med. Hypotheses 1979; 5: 1183
  • Kjellen P., Oldberg A., Rubin K., Hook M. Binding of heparin and heparan sulphate to rat liver cells. Biochem. Biophys. Res. Commun. 1977; 74: 126
  • Allalouf A., Ber A., Rechnic J., Sharon N. Anticoagulant properties of an acid mucopolysaccharide preparation isolated from rat kidney. Thromb. Diath. Haemorrh. 1967; 17: 264
  • Izuka K., Murata K. Inhibitory effects of human aortic and venous acid glycosaminoglycans on thrombus formation. Atherosclerosis 1972; 16: 217
  • Long W. F., Williamson F. B. Glycosaminoglycans, calcium ions and the control of cell proliferation. IRCS Med. Sci. 1979; 7: 429
  • Iozzo R. V., Bolender R. P., Wight T. Proteoglycan changes in the intercellular matrix of human colon carcinoma. An integrated biochemical and stereologic analysis. Lab. Invest. 1982; 47: 124
  • Ginetzinsky A. G. Role of hyaluronidase in the reabsorption of water in renal tubules. The mechanism of action of the anti-diuretic hormone. Nature (London) 1958; 182: 1218
  • Pinter G. G. A possible role of acid mucopolysaccharides in urine concentrating process. Experientia 1967; 23: 100
  • Wiederhielm C. A., Fox J. R., Lee D. R. Ground substance mucopolysaccharides and plasma proteins: their role in capillary water balance. Am. J. Physiol. 1976; 230: 1121
  • Snashall P. D. Mucopolysaccharide osmotic pressure in the measurement of interstitial pressure. Am. J. Physiol. 1977; 232: H608
  • Boss J. M. N., Breddy P., Cooper G. F. Variable and free mucopolysaccharides in the rat's kidney. J. Physiol. (London) 1961; 157: 35P
  • Breddy P., Cooper G. F., Boss J. M. N. Antidiuretic hormone and renal collecting tubules. Nature (London) 1961; 192: 76
  • Ivanova L. N., Vinogradov V. V. Histochemical features of mucopolysaccharides in interstitial tissue of renal medulla. Fed. Proc. Fed. Am. Soc. Exp. Biol. 1962; 22: 931
  • Vanhegan R. I. A method for the characterization of acid mucopolysaccharides in histological sections of renal medullae from animals in varying states of hydration. J. Physiol. (London) 1969; 192: 16P
  • Morard J.C., Abadie A. Fonction des mucopolysaccharides et des mucoides acides de la medullaire renale dans I'elaboration de l'urine. J. Physiol. (Paris) 1968; 60: 323
  • Farber S. J., Walat R. J., Benjamin R., Van Praag D. Effect of increased osmolality on glycosaminoglycan metabolism of rabbit renal papilla. Am. J. Physiol. 1971; 220: 880
  • Law R. O., Rowen D. The influence of hyaluronidase on urinary and renal medullary composition following antidiuretic stimulus in the rat. J. Physiol. 1981; 311: 341
  • Rowen D., Law R. O. Renal medullary hexosamine content following antidiuresis and water-loading in the rat. Effects of antisera against rat urinary and testicular hyaluronidase. Pfluegers Arch. 1981; 390: 152
  • Abrahams C., Pirani C. L. The renal papilla of the rat: electronmicroscopic and histochemical studies. S. Afr. J. Med. Sci. 1966; 31: 107
  • Blood M., Kupchella C. E. A correlation between kidney papillary glycosaminoglycan levels and the ability to concentrate urine in the rat. Fed. Proc. Fed. Am. Soc. Exp. Biol. 1980; 39: 949
  • Bengele H. H., Mathias R. S., Perkins J. H., Alexander E. A. Urinary concentrating defect in the aged rat. Am. J. Physiol. 1981; 240: F147
  • Sun C. N., White H. J., Towbin E. J. Histochemistry and electron microscopy of renal papilla in a genetic strain of rats with diabetic insipidus. Nephron 1972; 9: 308
  • McAuliffe W. G. The effects of anti-diuretic hormone on the morphology and histochemistry of the renal medullary interstitium of rats with hereditary hypothalamic diabetes insipidus (Brattleboro strain). Anat. Rec. 1978; 190: 474
  • Sun C. N. Effect of anti-diuretic hormone on the connective tissue of rat renal papilla. Exp. Pathol. 1980; 18: 469
  • Horobin R. W. The Use of Pure Dyes for Biological Staining. Koch Light Laboratories, SloughEngland 1980
  • Parsons C. L., Greenspan C., Mullholland S. G. The primary antibacterial defence mechanism of the bladder. Invest. Urol. 1975; 13: 72
  • Parsons C. L., Greenspan C., Moore S. W., Mulholland S. G. Role of surface mucin in primary antibacterial defence of bladder. Urology 1977; 9: 48
  • Parsons C. L., Mulholland S. G., Anwar H. Antibacterial activity of bladder surface mucin duplicated by exogenous glycosaminoglycan (hepain). Infect. Immun. 1979; 24: 552
  • Parsons C. L., Stauffer C., Schmidt J. D. Bladder-surface glycosaminoglycans: an efficient mechanism of environmental adaptation. Science 1980; 208: 605
  • Parsons C. L., Pollen J. J., Anwar H., Stauffer C., Schmidt J. D. Antibacterial activity of bladder surface mucin duplicated in the rabbit bladder by exogenous glycosaminoglycan. Infect. Immun. 1980; 27: 876
  • Parsons C. L., Stauffer C., Schmidt J. D. Impairment of antibacterial effect of bladder surface mucin by protamine sulfate. J. Infect. Dis. 1981; 144: 180
  • Parsons C. L. Prevention of urinary tract infection by the exogenous glycosaminoglycan sodium pentosanpolysulphate. J. Urol. 1982; 127: 167
  • Jarvinen A.K., Sandholm M. Urinary oligosaccharides inhibit adhesion ofE. coli onto canine urinary tract epithelium. Invest. Urol. 1980; 17: 443
  • Concepts in biochemical pharmacology. Handbook of Experimental Pharmacology, B. B. Brodie, J. R. Gillette, H. S. Ackerman. Springer-Verlag, Berlin 1971; Vol. 28, (part 2)
  • Boyd M. R., Grygiel J. J., Minchin R. F. Metabolic activation as a basis for organ-selective toxicity. Clin. Exp. Pharmacol. Physiol. 1983; 10: 87
  • Maher J. F. Effect of toxins on the kidney. Contrib. Nephrol. 1977; 7: 42
  • Anders M. W. Metabolism of drugs by the kidney. Kidney Int. 1980; 18: 636
  • Connelly J. C., Bridges J. W. The distribution and role of cytochrome P-450 in extrahepatic organs. Prog. Drug Metab. 1980; 5: 1
  • Kluwe W. M., Hook J. B. Effects of environmental chemicals on kidney metabolism and function. Kidney Int. 1980; 18: 648
  • Davis B. B., Mattammal M. B., Zenser T. V. Renal metabolism of drugs and xenobiotics. Nephron 1981; 27: 187
  • Rush G. F., Hook J. B. Renal drug metabolism and nephrotoxicity. Nephrotoxicity: Assessment and Pathogenesis, P. H. Bach, F. W. Bonner, J. W. Bridges, E. A. Lock. John Wiley & Sons, ChichesterEngland 1982; 237
  • Ormstad K. The use of isolated kidney cells, glomeruli and subcellular fractions for assessing renal function. Nephrotoxicity: Assessment and Pathogenesis, P. H. Bach, F. W. Bonner, J. W. Bridges, E. A. Lock. John Wiley & Sons, ChichesterEngland 1982; 161
  • Lock E. A. Renal necrosis produced by halogenated chemicals. Nephrotoxicity: Assessment and Pathogenesis, P. H. Bach, F. W. Bonner, J. W. Bridges, E. A. Lock. John Wiley & Sons, ChichesterEngland 1982; 396
  • Szefler S. J., Acara M. Isoproterenol excretion and metabolism in the isolated perfused rat kidney. J. Pharmacol. Exp. Ther. 1979; 210: 295
  • Elbers R., Kampffmeyer H. G., Rabes H. Effects and metabolic pathway of 4-dimethylamino-phenol during kidney perfusion. Xenobiotica 1980; 10: 621
  • Ross B., Tange J., Emslie K., Hart S., Small M., Calder I. Paracetamol metabolism by the isolated perfused rat kidney. Kidney Int. 1980; 18: 562
  • Emslie K. R., Clader I. C., Hart S. J., Tange J. D. Induction of paracetamol metabolism in the isolated perfused kidney. Xenobiotica 1981; 11: 579
  • Fry J. R., Wiebkin P., Kao J., Jones C. A., Gwynn J., Bridges J. W. A comparison of drug-metabolizing capability in isolated viable rat hepatocytes and renal tubule fragments. Xenobiotica 1978; 8: 113
  • Jones D. P., Sundby G.B., Ormstad K., Orrenlus S. Use of isolated kidney cells for study of drug metabolism. Biochem. Pharmacol. 1979; 28: 929
  • Szinicz L. L., Weger N. Effects of 4-dimethylaminophenol in rat kidneys, isolated rat kidney tubules and hepatocytes. Xenobiotica 1980; 10: 611
  • Litterst C. L., Mimnaugh E. G., Reagan R. L., Gram T. E. Comparison of in vitro drug metabolism by lung, liver, and kidney of several common laboratory species. Drug Metab. Dispos. 1975; 3: 259
  • Navran S. S., Louis-Ferdinand R. T. p-Chloro-N-methylaniline demethylation by rat kidney subcellular fractions. Res. Commun. Chem. Pathol. Pharmacol. 1975; 12: 713
  • Litterst C. L., Mimnaugh E. G., Reagan R. L., Gram T. E. Drug metabolism by microsomes from extrahepatic organs of rat and rabbit prepared by calcium aggregation. Life Sci. 1975; 17: 813
  • Litterst C. L., Mimnaugh E. G., Gram T. E. Comparative alterations in extrahepatic drug metabolism by factors known to affect hepatic activity. Biochem. Pharmacol. 1977; 26: 749
  • Magos L. Mecury induced nephrotoxicity. Nephrotoxicity: Assessment and Pathogenesis, P. H. Bach, F. W. Bonner, J. W. Bridges, E. A. Lock. John Wiley & Sons, ChichesterEngland 1982; 325
  • Armbrecht H. J., Bimbaum L. S., Zenser T. V., Mattammal M. B., Davis B. B. Renal cytochrome P-450s – electrophoretic and electron paramagnetic resonance studies. Arch. Biochem. Biophys. 1979; 197: 277
  • Gnengerich F. P., Mason P. S. Immunological comparison of hepatic and extrahepatic cytochromes P-450. Mol. Pharmacol. 1979; 15: 154
  • Kaminsky L. S., Fasco M. J., Guengrich F. P. Comparison of different forms of liver, kidney, and lung microsomal cytochrome P-450 by immunological inhibition of regio- and stereoselective metabolism of warfarin. J. Biol. Chem. 1979; 254: 9657
  • Zenser T. V., Mattammal M. B., Davis B. B. Differential distribution of the mixed-function oxidase activities in rabbit kidney. J. Pharmacol. Exp. Ther. 1978; 207: 719
  • Sikic B. I., Mimnaugh E. G., Litterst C. L., Gram T. E. The effects of ascorbic acid deficiency and repletion on pulmonary, renal, and hepatic drug metabolism in the guinea pig. Arch. Biochem. Biophys. 1977; 179: 663
  • Biological reactive intermediates. Formation, Toxicity and Inactivation, D. J. Jollow, J. J. Kocsis, R. Snyder, H. Vainio. Plenum Press, New York 1976
  • Biological Reactive Intermediates, Part II, R. Snyder, D. V. Parke, J. J. Kocsis, D. J. Jollow, G. G. Gibson. Plenum Press, New York 1981
  • Dees J. H., Parkhill L. K., Okita R. T., Yasukochi Y., Masters B. S. Localization of NADPH-cytochrome P-450 reductase and cytochrome P-450 in animal kidney. Nephrotoxicity: Assessment and Pathogenesis, P. H. Bach, F. W. Bonner, J. W. Bridges, E. A. Lock. John Wiley & Sons, ChichesterEngland 1982; 246
  • Powell C. J., Gibson G. G., Bach P. H., Bridges J. W. 1983, unpublished data
  • Zenser T. V., Mattammal M. B., Davis B. B. Demonstration of separate pathways for the metabolism of organic compounds in rabbit kidney. J. Pharmacol. Exp. Ther. 1979; 208: 418
  • Zenser T. V., Mattammal M. B., Brown W. W., Davis B. B. Cooxygenation by prostaglandin cyclooxygenase from rabbit inner medulla. Kidney Int. 1979; 16: 688
  • Joshi S., Zenser T. V., Mattammal M. B., Herman C. A., Davis B. B. Kidney metabolism of acetaminophen and phenacetin. J. Lab. Clin. Med. 1978; 92: 924
  • Moldeus P., Rahimtula A. Metabolism of paracetamol to a glutathione conjugate catalyzed by prostaglandin synthetase. Biochem. Biophys. Res. Commun. 1980; 96: 469
  • Boyd J. A., Eling T. E. Prostaglandin endoperoxide synthetase-dependent cooxidation of acetaminophen to intermediates which covalently bindin vitro to rabbit renal medullary microsomes. J. Pharmacol. Exp. Ther. 1981; 219: 659
  • Mohandas J., Duggin G. G., Horvath J. S., Tiller D. J. Regional differences in peroxidatic activation of paracetamol (acetaminophen) mediated by cytochrome P-450 and prostaglandin endoperoxide synthetase in rabbit kidney. Res. Commun. Chem. Pathol. Pharmacol. 1981; 34: 69
  • Mohandas J., Duggin G. G., Horvath J. S., Tiller D. J. Metabolic oxidation of acetaminophen (paracetamol) mediated by cytochrome P-450 mixed function oxidase and prostaglandin endoperoxide synthetase in rabbit kidney. Toxicol. Appl. Pharmacol. 1981; 61: 252
  • Zenser T. V., Mattammal M. B., Rapp N. S., Davis B. B. Effect of aspirin on metabolism of acetaminophen and benzidine by renal inner medulla prostaglandin hydroperoxidase. J. Lab. Clin. Med. 1983; 101: 58
  • Zenser T. V., Davis B. B. Enzyme systems involved in the formation of reactive metabolites in the renal medulla. Fundam. Appl. Toxicol. 1984; 4: 922
  • Zenser T. V., Mattammal M. B., Davis B. B. Co-oxidative metabolism of 2-amino-4-(5-nitro-2-furyl)-thiazole by prostaglandin hydroperoxidase. J. Lab. Clin. Med. 1980; 96: 425
  • Zenser T. V., Mattammal M. B., Davis B. B. Co-oxidation of benzidine by renal medullary prostaglandin cyclooxygenase. J. Pharmacol. Exp. Ther. 1980; 211: 460
  • Andersson B., Larsson R., Rahimtula A., Moldeus P. Hydroperoxide-dependent activation of p-phenetidine catalyzed by prostaglandin synthase and other peroxidases. Biochem. Pharmacol. 1983; 32: 1045
  • Kadlubar F. F., Frederick C. B., Weis C. C., Zenser T. V. Prostaglandins endoperoxide synthetase-mediated metabolism of carcinogenic aromatic amines and their binding to DNA and protein. Biochem. Biophys. Res. Commun. 1982; 108: 253
  • Mattammal M. B., Zenser T. V., Davis B. B. Prostaglandin hydroperoxidase-mediated 2-amino-4(5-nitro-2-furyl) [14C]-thiazole metabolism and nucleic acid binding. Cancer Res. 1981; 41: 4961
  • Eling T., Boyd J., Reed G., Mason R., Sivarajah K. Xenobiotic metabolism by prostaglandin endoperoxide synthetase. Drug Metab. Rev. 1983; 14: 1023
  • Marnett L. J. Polycyclic aromatic hydrocarbon oxidation during prostaglandin biosynthesis. Life Sci. 1981; 29: 531
  • Marnett L. J., Reed G. A. Peroxidatic oxidation of benzo[a]pyrene and prostaglandin biosynthesis. Biochemistry 1979; 18: 2923
  • Wise R. W., Zenser T. V., Davis B. B. Prostaglandin H synthase metabolism of the urinary bladder carcinogens benzidine and ANFT. Carcinogenesis 1983; 4: 285
  • Sawahata T., Neal R. A. Horseradish peroxidase-mediated oxidation of phenol. Biochem. Biophys. Res. Commun. 1982; 109: 988
  • Corbett M. D., Baden D. G., Chipko B. R. Arylamine oxidations by chloroperoxidase. Bioorg. Chem. 1979; 8: 91
  • Corbett M. D., Chipko B. R., Baden D. G. Chloroperoxidase-catalysed oxidation of 4-chloroaniline to 4-chloronitrosobenzene. Biochem. J. 1978; 175: 353
  • Bakkenist A. R. J., Platt H., Weaver R. Oxidation of 4-chloroaniline catalysed by human myeloperoxidase. Bioorg. Chem. 1981; 10: 324
  • Egan R. W., Gale P. H., Baptista E. M., Kennicott K. L., Van den Heuvel W. J. A., Walker R. W., Fagerness P. E., Kuehl F. A. Oxidation reactions by prostaglandin cyclooxygenase-hydroperoxide. J. Biol. Chem. 1981; 256: 7352
  • Zenser T. V., Mattammal M. B., Armbrech H. J., Davis B. B. Benzidine binding to nucleicacid mediated by the peroxidative activity of prostaglandin endoperoxide synthetase. Cancer Res. 1980; 40: 2839
  • Zenser T. V., Cohen S. M., Mattammal M. B., Wise R. W., Rapp N. S., Davis B. B. Prostaglandin hydroperoxidase-catalyzed activation of certain N-substituted aryl renal and bladder carcinogens. Environ. Health Perspect. 1983; 49: 33
  • Marnett L. J., Reed G. A., Dennison D. J. Prostaglandin synthetase dependent activation of 7,8-dihydro-7,8-hiydroxybenzo[a]pyrene to mutagenic derivatives. Biochem. Biophys. Res. Commun. 1978; 82: 210
  • Nelson S. D., Dahlin D. C., Rauckman R. J., Rosen G. M. Peroxidase-mediated formation of reactive metabolites of acetaminophen. Mol. Pharmacol. 1981; 20: 195
  • Bach P. H., Bridges J. W. The role of prostaglandin synthetase mediated metabolic activation of analgesics and non-steroidal antiinflammatory drugs in the development of renal papillary necrosis and upper urothelial carcinoma. Prostaglandins Leuk. Med. 1985; 15: 251
  • Caldwell J., Marsh M. V. Interrelationships between xenobiotic metabolism and lipid biosynthesis. Biochem. Pharmacol 1983; 32: 1667
  • Fears R., Baggaley K. H., Alexander R., Morgan B., Hindley M. The participation of ethyl 4-benzyloxybenzoate (BRL 10894) and other aryl-substituted acids in glycerolipid metabolism. J. Lipid Res. 1978; 19: 3
  • Fears R., Richards D. H. Association between lipid-lowering activity of aryl-substitute carboxylic acids and formation of substituted glycerolipids in rats. Biochem. Soc. Trans. 1981; 9: 572
  • Dell H.D., Fielder J., Kamp R., Gau W., Kurz J., Weber B., Wuensche C. Etofenamate fatty acid esters, an example of a new route of drug metabolism. Drug Metab. Dispos. 1982; 10: 66
  • Von Friedreich N. Ueber Necrose der Niereupapilleu bei Hydronephrose. Virchows Arch. A 1877; 69: 308
  • Turner F. C. A kidney from a case of phthisis, showing mortification of the apices of the pyramids. Trans. Pathol. Soc. (London) 1885; 36: 268
  • Turner F. C. Necrosis with softening in pyramids of the kidneys; recent endopericarditis. Trans. Pathol. Soc. (London) 1886; 36: 290
  • Turner F. C. Necrosis of the pyramids of one kidney. Trans. Pathol. Soc. (London) 1888; 39: 159
  • Mandel E. E. Renal medullary necrosis. Am. J. Med. 1952; 13: 322
  • Spühler O., Zollinger H. U. Die Chronische-interstitielle Nephritis. Z. Klin. Med. 1953; 151: 1
  • Murray T. G. Analgesic use and kidney disease. Arch. Intern. Med. 1981; 141: 423
  • Murray T. G., Goldberg M. Analgesic associated nephropathy in the U.S.A.: epidemiologic, clinical and pathogenic features. Kidney Int. 1978; 13: 64
  • Gonwa T. A., Hamilton R. W., Buckalew V. M. Chronic renal failure and end-stage renal disease in northwest North Carolina. Importance of analgesic-associated nephropathy. Arch. Intern. Med. 1981; 141: 462
  • Knapp M., Avioli L. V. Analgesic nephropathy. Arch. Intern. Med. 1982; 142: 1197
  • Dubach U. C., Rosner B., Levy P. S., Baumeler H.R., Muller A., Peyer A., Ehrensperger T., Ettlin C. Epidemiological study in Switzerland. Kidney Int. 1978; 13: 41
  • Murray R. M. The geographical distribution of analgesic nephropathy. Health Bull. (Edinburgh) 1972; 31: 32
  • Murray R. M. Genesis of analgesic nephropathy in the United Kingdom. Kidney Int. 1978; 13: 50
  • Bell D., Kerr D. N. S., Swinney J., Yeates W. K. Analgesic nephropathy. Clinical course after withdrawal of phenacetin. Br. Med. J. 1969; 3: 378
  • Bengtsson U. A comparative study of chronic non-obstructive pyelonephritis and renal papillary necrosis. Acta Med. Scand. Suppl. 1962; 388: 1
  • Dubach U. C., Levy P. S., Rosner B., Baumeler H. R., Peier A., Ehrensperger T. Relation between regular intake of phenacetin-containing analgesics and laboratory evidence for urorenal disorders in a working female population of Switzerland. Lancet 1975; 1: 539
  • McLachlan M. S. F. The ageing kidney. Lancet 1978; 2: 143
  • Emkey R. D., Mills J. A. Aspirin and analgesic nephropathy. JAMA 1982; 247: 55
  • Dubach U. C., Rosner B., Pfister E. Epidemiologic study of abuse of analgesics containing phenacetin. Renal morbidity and mortality (1968–1979). N. Engl. J. Med. 1983; 308: 357
  • Alt J. M., Janig H., Schurek H. J., Stolte H. Study of renal protein excretion in chronic pyelonephritis. Contrib. Nephrol. 1979; 16: 37
  • Alt J. M., Deerberg F., Hackbarth H.J., Stolte H. The study of urinary protein excretion in male rats as compared with human proteinuria. Contrib. Nephrol. 1980; 19: 79
  • Alt J. M., Hacke H., von der Heyde D., Janig H., Junge P.M., Olbricht Ch., Schurek H.J., Stolte H. Urinary protein excretion in interstitial and tubular kidney disease as characterized by gradient electrophoresis. Klin. Wochenschr. 1983; 61: 641
  • Russ G. R., Horgan B. A., Mathew T. H., Brown H., Mills L., Kirkland J. A. Beta 2-microglobulin excretion and urinary cytology in analgesic nephropathy. Clin. Nephrol. 1982; 18: 148
  • Fowler J. S. L. Micro-, middle and macromolecules in blood and urine. Nephrotoxicity: Assessment and Pathogenesis, P. H. Bach, F. W. Bonner, J. W. Bridges, E. A. Lock. John Wiley & Sons, ChichesterEngland 1982; 66
  • Steele T. W., Gyory A. Z., Edwards K. D. G. Renal function in analgesic nephropathy. Br. Med. J. 1969; 2: 213
  • Jaeger P., Burckhardt P., Wauters J. P., Trechsel U., Bonjour J. P. Atteinte particulierement sévére du metabolisme calcique dans la néphropathie par abus d'analgesiques. Schweiz. Med. Wochenschr. 1982; 112: 1791
  • Fassett R. G., Lien J. W. K., McClure J., Mathew T. H. Bone disease in analgesic nephropathy. Clin. Nephrol. 1982; 18: 273
  • Price R. G. Urinary enzymes, nephrotoxicity and renal disease. Toxicology 1982; 23: 99
  • Lindvall N. Renal papillary necrosis. Acta Radiol. Suppl. 1960; 192: 1
  • Lindvall N. Radiological changes of renal papillary necrosis. Kidney Int. 1978; 13: 93
  • Hare W. S. C., Poynter J. D. The radiology of renal papillary necrosis as seen in analgesic nephropathy. Clin. Radiol. 1974; 25: 423
  • Hoffman J. C., Schnur M. J., Koenigsberg M. Demonstration of renal papillary necrosis by sonography. Radiology 1982; 145: 785
  • Fourie I. J. V. H., Pauw F. H., de Bruin B. Bladder urothelium in analgesic-associated nephropathy – a valuable diagnostic aid. J. Urol. 1982; 128: 262
  • Mihatsch M. J., Torhorst J., Steinmann E., Hofer H., Stickelberger M., Bianchi L., Berneis K., Zollinger H. U. The morphologic diagnosis of analgesic (phenacetin) abuse. Pathol. Res. Pract. 1979; 164: 68
  • Mihatsch M. J., Torhorst J., Amsler B., Zollinger H. U. Capillarosclerosis of the lower urinary tract in analgesic (phenacetin) abuse. An electron-microscope study. Virchows Arch. A 1978; 381: 41
  • Mihatsch M. J., Hofer H. O., Gudat F., Knusli C., Torhorst J., Zollinger U. Capillary sclerosis of the lower urinary tract and analgesic nephropathy. Clin. Nephrol. 1984; 20: 285
  • Munck A., Lindlar F., Masshoff W. Die Pigmentierung der Nierenpapillen und der Schleimhaut der ableitenden Harnwege bei der chronischen sklerosierenden interstitiellen Nephritis (“Phenacetinniere”). Virchows Arch. A 1970; 349: 323
  • Gloor F. J. Changing concepts in pathogenesis and morphology of analgesic nephropathy as seen in Europe. Kidney Int. 1978; 13: 27
  • Gloor F. Die Kapillarosklerose in den ableitenden Harnwegen bei Schmerzmittel-(Phenazetin)-Missbrauch. Pathologe 1982; 3: 132
  • Karttunen T., Autio-Harmainen H., Sutinen S. Capillarosclerosis of the urinary tract associated with the use of paracetamol and cyclophosphamide. Acta Pathol. Microbiol. Immunol. Scand. Sect. A 1982; 90: 391
  • Goldberg L. E., Talner L. B. Analgesic abuse syndrome. Urology 1975; 5: 728
  • Von Schumann G., Lickint F. Uber Phenacetinabusus und seine Folgen, zugleich ein kasuistischer Beitrag zur sogenannten Phenacetin-Nephritis. Dtsch. Gesundheitswes 1959; 14: 348
  • Murray T. G., Stolley P. D., Anthony J. C., Schinnar R., Hepler-Smith E., Jeffreys J. L. Epidemologic study of regular analgesic use and end-stage renal disease. Arch. Intern. Med. 1983; 143: 1687
  • McAnally J. F., Winchester J. F., Schreiner G. E. Analgesic nephropathy. An uncommon cause of end-stage renal disease. Arch. Intern. Med. 1983; 143: 1897
  • Gilman A. Analgesic nephrotoxicity. Am. J. Med. 1964; 36: 167
  • Dubach U. C., Levy P. S., Minder F. Epidemiological study of analgesic intake and its relationship to urinary tract disorders in Switzerland. Helv. Med. Acta 1968; 34: 297
  • Dubach U. C., Levy P. S., Muller A. Relationships between regular analgesic intake and urorenal disorders in a working female population of Switzerland. I. Initial results. Am. J. Epidemiol. 1971; 93: 425
  • Prescott L. F., Sansur M., Levin W., Conney A. H. The comparative metabolism of phenacetin and N-acetyl-p-amiophenol in man, with particular reference to effects on the kidney. Clin. Pharmacol. Ther. 1968; 9: 605
  • Kuntzmann R., Pantuck E. J., Kaplan S. A., Conney A. H. Phenacetin metabolism: effect of hydrocarbons and cigarette smoking. Clin. Pharmacol. Ther. 1977; 22: 757
  • Brodie B. B., Axelrod J. The estimation of acetanilide and its metabolic products, aniline, N-acetyl-p-aminophenol and p-aminophenol (free and total conjugated) in biological fluids and tissues. J. Pharmacol. Exp. Ther. 1948; 94: 22
  • Prescott L. F. The metabolism of phenacetin in patients with renal disease. Clin. Pharmacol. Ther. 1969; 10: 383
  • Furman K. I., Galasko G. T. F., Block C. S. Decreased drug conjugation as a pathogenic factor in the aetiology of analgesic nephropathy. Proc. EDTA 1976; 13: 433
  • Nanra R. S., Kincaid-Smith P. Renal papillary necrosis in rheumatoid arthritis. Med. J. Aust. 1975; 1: 194
  • Wortmann D. W., Kelsch R. C., Kuhns L., Sullivan D. B., Cassidy J. T. Renal papillary necrosis in juvenile rheumatoid arthritis. J. Pediatr. 1980; 97: 37
  • Akyol S. M., Thompson M., Kerr D. N. S. Renal function after prolonged consumption of aspirin. Br. Med. J. 1982; 284: 631
  • Gall E. P. The safety of treating rheumatoid arthritis with aspirin. JAMA 1982; 247: 63
  • Husserl F. E., Lange R. K., Kantrow C. M. Renal papillary necrosis and pyelonephritis accompanying fenoprofen therapy. JAMA 1979; 242: 1896
  • Prescott L. F. The nephrotoxicity and hepatotoxicity of antipyretic analgesics. Br. J. Clin. Pharmacol. 1979; 7: 453
  • Robertson C. E., Ford M. J., Van Someren V., Dlugolecka M., Prescott L. F. Mefenamic acid nephropathy. Lancet 1980; 2: 232
  • Muhalwas K. K., Shah G. M., Winer R. L. Renal papillary necrosis caused by long-term ingestion of pentazocine and aspirin. JAMA 1981; 246: 867
  • Shah G. M., Muhalwas K. K., Winer R. L. Renal papillary necrosis due to ibuprofen. Arthritis Rheum. 1981; 24: 1208
  • Mease P. J., Ellsworth A. J., Killen P. D., Willkens R. F. Zomepirac, interstitial nephritis and renal failure. Ann. Intern. Med. 1982; 97: 454
  • Erwin L., Boulton Jones J.M. Benoxaprofen and papillary necrosis. Br. Med. J. 1982; 285: 649
  • Mitchell H., Muirden K. D., Kincaid-Smith P. Indomethacin-induced renal papillary necrosis in juvenile chronic arthritis. Lancet 1982; 2: 558
  • Hoffbrand B. I. Dapsone and renal papillary necrosis. Br. Med. J. 1978; 1: 78
  • Gilbert E. F., Khoury G. H., Hogan G. R., Jones B. Hemorrhagic renal nerosis in infancy: relationship to radiopaque compounds. J. Pediatr. 1970; 76: 49
  • Solez K., Miller M., Quarles P. A., Finer P. M., Heptinstall R. H. Experimental papillary necrosis of the kidney. IV. Medullary plasma flow. Am. J. Pathol. 1974; 76: 521
  • Salisbury R. M., McIntosh I. G., Staples E. L. J. Mortality in lambs and cattle following the administration of phenothiazine. N. Z. Vet. J. 1969; 17: 227
  • Lucke V. M., Hunt A. C. Interstitial nephropathy and papillary necrosis in the domestic cat. J. Pathol. Bacteriol. 1963; 89: 723
  • Lucke V. M. Renal disease in the domestic cat. J. Pathol. Bacteriol. 1968; 95: 67
  • Burry A. Pathology of analgesic nephropathy: Australian experience. Kidney Int. 1978; 13: 34
  • Wilson D. R., Gault M. H. Declining incidence of analgesic nephropathy in Canada. Can. Med. Assoc. J. 1982; 127: 500
  • Bluemle L. W., Goldberg M. Renal accumulation of salicylate and phenacetin. Possible mechanisms in the nephropathy of analgesic abuse. J. Clin. Invest. 1968; 47: 2507
  • Mitchell J. R., McMurtry R. J., Statham C. N., Nelson S. D. Molecular basis for several drug-induced nephropathies. Am. J. Med. 1977; 62: 518
  • Zollinger H. U. 25 Jahre Phenacetimabusus. Schweiz. Med. Wochenschr. 1980; 110: 106
  • Mihatsch M. J., Hofer H. O., Gutzwiler F., Brunner F. P., Zollinger H. U. Phenacetinabusus. I. Haufigkeit, Pro-Kopf-Verbrauch und Folgekosten. Schweiz. Med. Wochenschr. 1980; 110: 108
  • Mihatsch M. J., Schmidlin P., Brunner F. P., Hofer H. O., Six P., Zollinger H. U. phenacetinabusus. II. Die chronische renale Niereninsuffizienz un Basler Autopsiegut. Schweiz. Med. Wochenschr. 1980; 110: 255
  • Mihatsch M. J., Manz T., Knusli C., Hofer H. O., Rist M., Guetg R., Rutishauser G., Zollinger H. U. Phenacetinabusus. III. Maligne Harnwegtumoren bie phenacetinabusus in Basel 1963–1977. Schweiz. Med. Wochenschr. 1980; 110: 255
  • Dalquen P., Fasel J., Mihatsch M. J., Rist M., Rutishauser G. Phenacetinabusus. IV. Sind zytologische Hamuntersuchungen in der Tumorvorsorge bei Phenacetinabusem er folgversprechend und anwendbar. Schweiz. Med. Wochenschr. 1980; 110: 302
  • Gault M. H., Blennerhassett J., Muehrcke R. C. Analgesic nephropathy. A clinicopatholigic study using electron microscopy. Am. J. Med. 1971; 51: 740
  • Burry A. F. The evolution of analgesic nephropathy. Nephron 1968; 5: 185
  • Blohme I., Johansson S. Renal pelvic neoplasms and atypical urothelium in patients with end-stage analgesic nephropathy. Kidney Int. 1981; 20: 671
  • MacGregor G. A., Jones N. F., Barraclough M. A., Wing A. J., Cranston W. I. Ureteric stricture with analgesic nephropathy. Br. Med. J. 1973; 2: 271
  • Lewis C. T., Molland E. A., Marshall V. F., Tresidder G. C., Blandy J. P. Analgesic abuse, ureteric obstruction and retroperitoneal fibrosis. Br. Med. J. 1975; 2: 76
  • Bergman S., Forrest J., Betsill W., Gillenwater J. Acquired upper ureteral stricture in a phenacetin abuser. J. Urol. 1980; 124: 892
  • Finan B. F., Finkbeiner A. E. Renal papillary necrosis and retroperitoneal fibrosis secondary to analgesic abuse. J. Urol. 1981; 126: 533
  • Kingsley D. P. E., Goldberg B., Abrahams C., Meyers A. J., Furman K. I., Cohen I. Analgesic nephropathy. Br. Med. J. 1972; 4: 656
  • Bengtsson U., Angervall L., Ekman H., Lehmann L. Transitional cell tumors of the renal pelvis in analgesic abusers. Scand. J. Urol. Nephrol. 1968; 2: 145
  • Bengtsson U., Johansson S., Angervall L. Malignancies of the urinary tract and their relation to analgesic abuse. Kidney Int. 1978; 13: 107
  • Johansson S., Angervall L., Bengtsson U., Wahlqvist L. Uroepithelial tumours of the renal pelvis associated with abuse of phenacetin-containing analgesics. Cancer 1974; 33: 743
  • McCredie M., Ford J. M., Taylor J. S., Stewart J. H. Analgesics and cancer of the renal pelvis in New South Wales. Cancer 1982; 49: 2617
  • McCredie M., Stewart J. H., Mahony J. F. Is phenacetin responsible for analgesic nephropathy in New South Wales?. Clin. Nephrol. 1982; 17: 134
  • McCredie M., Stewart J. H., Ford J. M., MacLennan R. A. Phenacetin-containing analgesics and cancer of the bladder or renal pelvis in woman. Br. J. Urol. 1983; 55: 220
  • Chernozemsky I. N., Stoyanov I. S., Petkova-Bocharova T. K., Nicolov I. G., Draganov I. V., Stoichev I. I., Tanchev Y., Naidenov D., Kalcheva N. D. Geographic correlation between the occurrence of endemic nephropathy and urinary tract tumours in Vratza district, Bulgaria. Int. J. Cancer 1977; 19: 1
  • Mahony J. F., Storey B. G., Ibanez R. C., Stewart J. H. Analgesic abuse, renal parenchymal disease and carcinoma of the kidney or ureter. Aust. N. Z. J. Med. 1977; 7: 463
  • Gonwa T. A., Corbett W. T., Schey H. M., Buckalew V. M. Analgesic-associated nephropathy and transitional cell carcinoma of the urinary tract. Ann. Intern. Med. 1980; 93: 249
  • Porpaczy P., Schramek P. Analgesic nephropathy and phenacetin-induced transitional cell carcinoma – analysis of 300 patients with long-term consumption of phenacetin-containing drugs. Eur. Urol. 1981; 7: 349
  • Lomax-Smith J. D., Seymour A. E. Neoplasia in analgesic nephropathy. A urothelial field change. Am. J. Surg. Pathol. 1980; 4: 565
  • Lomax-Smith J., Seymour A. E. Unsuspected analgesic nephropathy in transitional cell carcinoma of the upper tract: a morphological study. Histopathology 1980; 4: 255
  • Handa S. P., Tewari H. D. Urinary tract carcinoma in patients with analgesic nephropathy. Nephron 1981; 28: 62
  • Johansson S., Angervall L., Bengtsson U., Wahlqvist L. A clinicopathologic and prognostic study of epithelial tumors of the renal pelvis. Cancer 1976; 37: 1376
  • Johansson S. Studies on Epithelial Renal Pelvic Tumors. M.D. thesis, University of Gothenburg, Sweden 1976
  • Gatewood O. M. B., Goldman S. M., Marshall F. F., Siegelman S. S. Computerized tomography in the diagnosis of transitional cell carcinoma of the kidney. J. Urol. 1982; 127: 876
  • Huffam J. L., Bagley D. H., Lyon E. S. Extending cytoscopic techniques into the ureter and renal pelvis. JAMA 1983; 250: 2002
  • Esposti P. L., Moberger G., Zajicek J. The cytologic diagnosis of transitional cell tumours of the urinary bladder and its histological basis. Acta Cytol. 1970; 14: 145
  • Boon M. E., Kurver P. H. J., Baak J. P. A., Ooms E. C. M. Morphometric differences between urothelial cells in voided urine of patients with grade I and grade II bladder tumours. J. Clin. Pathol. 1981; 34: 612
  • Brodie B. B., Axelrod J. The estimation of acetanilide and its metabolic products, aniline, N-acetyl-p-aminophenol and p-aminophenol (free and total conjugated), in biological fluids and tissues. J. Pharmacol. Exp. Ther 1948; 94: 22
  • Hardy T. L. The Early Detection of Drug Induced Renal Tubular Damage in the Rat. M.I. Biol. thesis, Institute of Biology, London 1968
  • Fischer S., Neilsen M. L., Clausen S., Vogelsang M., Hogsborg E. Increased abnormal urothelial cells in voided urine following excretory urography. Acta Cytol. 1982; 26: 153
  • Lewis R. W., Jackson A. C., Murphy W. M., Leblanc G. A., Meehan W. L. Cytology in the diagnosis and followup of transitional cell carcinoma of the urothelium: a review with a case series. J. Urol. 1976; 116: 43
  • Eriksson O., Johansson S. Urothelial neoplasms of the upper urinary tract: a correlation between cytologic and histologic findings in 43 patients with urothelial neoplasms of the renal pelvis or ureter. Acta Cytol. 1976; 20: 20
  • Sarnacki C. T., McCormack L. J., Kiser W. S., Hazard J. B., McLaughlin T. C., Belovich D. M. Urinary cytology and the clinical diagnosis of urinary tract malignancy: a clinicopathologic study of 1,400 patients. J. Urol. 1971; 106: 761
  • Jackson B., Kirkland J. A., Lawrence J. R., Narayan A. S., Brown H. E., Mills L. R. Urine cytology findings in analgesic nephropathy. J. Urol. 1978; 120: 145
  • Gault M. H., Oliver J. A., Lang C., Asghar M. I., Levy S. W. Urinary enzymes in benign and malignant urinary tract disorders: alkaline phosphatase and lactic acid dehydrogenase. Br. J. Urol. 1967; 39: 296
  • Shuster J., Gold P., Poulik M. D. Beta 2-microglobulin levels in cancerous and other disease states. Clin. Chim. Acta 1976; 67: 307
  • Teasdale C., Mauder A. M., Fifield R., Keyser J. W., Newcombe R. G., Hughes L. E. Serum beta 2-microglobulin in controls and cancer patients. Clin. Chim. Acta 1977; 78: 135
  • Nilsson K., Evrin P.E., Welsh K. I. Production of β2-microglobin by normal and malignant human cell lines and peripheral lymphocytes. Transplant. Rev. 1974; 21: 53
  • Sattler T. A., Dimitrov Ts., Hall P. W. Relation between endemic (Balkan) nephropathy and urinary-tract tumours. Lancet 1977; 1: 278
  • Hicks R. M. Effect of promoters on incidence of bladder cancer in experimental animal models. Environ. Health Perspect. 1983; 50: 37
  • Hicks R. M. Multistage carcinogenesis in the urinary bladder. Br. Med. Bull. 1980; 36: 39
  • Hicks R. M. Pathological and biochemical aspects of tumour promotion. Carcinogenesis 1983; 4: 1209
  • Chasko S. B., Gray G. F., McCarron J. P. Urothelial neoplasia of the upper urinary tract. Pathol. Annu. 1981; 16: 127
  • Mihatsch M. J., Knusli K. Phenacetin abuse and malignant tumours. An autopsy study covering 25 years (1953–1977). Klin. Wochenschr. 1982; 60: 1339
  • Bergkvist A., Ljungqvist A., Moberger G. Classification of bladder tumours based on the cellular pattern. Preliminary report of a clinical-pathological study of 300 cases with a minimum follow-up of eight years. Acta Chir. Scand. 1965; 130: 371
  • Johansson S., Wahlqvist L. Tumours of urinary bladder and ureter associated with abuse of phenacetin-containing analgesics. Acta Pathol. Microbiol. Scand. Sect. A 1977; 85: 768
  • Hultengren N., Lagergren C., Ljungqvist A. Carcinoma of the renal pelvis in renal papillary necrosis. Acta Chir. Scand. 1965; 130: 314
  • Clark W. F., Linton A. L. The problem of analgesic nephropathy. Clin. Toxicol. 1973; 6: 39
  • Newberne P. M. Environmental modifiers of susceptibility to carcinogens. Cancer Detect. Prev. 1976; 1: 129
  • Beyer-Boon M. E., Cuypers L. H. R. I., de Voogt H. J., Brussee J. A. M. Cytological changes due to urinary calculi: a consideration of the relationship between calculi and the development of urothelial carcinoma. Br. J. Urol. 1978; 50: 81
  • Abul-Fadl M. A. M., Khalafallah A. S. Studies on the urinary excretion of certain tryptophan metabolites in bilharziasis and its possible relation to bladder cancer in Egypt. Br. J. Cancer 1961; 17: 137
  • Abul-Fadl M. A. M., Metwalli O. M. Studies on certain urinary and blood serum enzymes in bilharziasis and their possible relation to bladder cancer in Egypt. Br. J. Cancer 1963; 17: 137
  • Taylor J. S. Carcinoma of the urinary tract and analgesic abuse. Med. J. Aust. 1972; 1: 407
  • Cheng L. Urinary tract calculi in man and laboratory animals: incidence, composition, and etiology. J. Environ. Pathol. Toxicol. 1980; 4: 317
  • Fairchlld C. R., Solomon H. D., Gangal M. P. Incidence of bladder-cancer after cyclophosphamide therapy. J. Urol. 1979; 122: 163
  • Pearson R. M., Soloway M. S. Does cyclophosphamide induce bladder cancer?. Urology 1978; 11: 437
  • Analgesic mixtures containing phenacetin. IARC Monograph. International Agency for Research on Cancer, LyonFrance 1982; 135, Suppl. 4
  • Phenacetin. IARC Monograph. International Agency for Research on Cancer, LyonFrance 1980; Vol. 24: 47
  • McCredie M., Stewart J. H., Ford J. M. Analgesics and tobacco as risk factors for cancer of the ureter and renal pelvis in men. J. Urol. 1983; 130: 28
  • Schmauz R., Cole P. Epidemiology of cancer of the renal pelvis and ureter. J. Natl. Cancer Inst. 1974; 52: 1431
  • Mommsen S., Aagaard J. Tobacco as a risk factor in bladder cancer. Carcinogenesis 1983; 4: 335
  • Cole P. Coffee-drinking and cancer of the lower urinary tract. Lancet 1971; 1: 1335
  • Stolte H., Alt J. Research animals and experimental design in nephrology. Contrib. Nephrol. 1980; 19: 1
  • Snell K. C. Renal disease of the rat. Pathology of Laboratory Rats and Mice, E. Cotchin, F. J. C. Roe. Blackwell Scientific, Oxford 1967; 105
  • Zbinden G. Experimental renal toxicity. The Kidney, C. Rouiller, A. F. Muller. Academic Press, New York 1969; Vol. 2: 401
  • Stolte H., Alt J. M. The choice of animals for nephrotoxic investigations. Nephrotoxicity: Assessment and Pathogenesis, P. H. Bach, F. W. Bonner, J. W. Bridges, E. A. Lock. John Wiley & Sons, ChichesterEngland 1982; 102
  • Mudge G. H. Comparative pharmacology of the kidney: implications for drug-induced renal failure. Nephrotoxicity: Assessment and Pathogenesis, P. H. Bach, F. W. Bonner, J. W. Bridges, E. A. Lock. John Wiley & Sons, ChichesterEngland 1982; 504
  • Burek J. D. The urinary system. Pathology of Aging Rats. CRC Press, Boca Raton, Fla 1978; 97
  • Urinary system – spontaneous lesions. Animal Models of Human Disease, E. J. Andrew, B. C. Ward, N. H. Altman. Academic Press, New York 1979; Vol. 2: 267, (Part 16)
  • Bach P. H., Lock E. A. The use of renal tissue slices, perfusion and infusion techniques to assess renal function and malfunction. Nephrotoxicity: Assessment and Pathogenesis, P. H. Bach, F. W. Bonner, J. W. Bridges, E. A. Lock. John Wiley & Sons, ChichesterEngland 1982; 128
  • Bach P. H. 1984, unpublished data
  • Macklin A. W., Szot R. J. Eighteen month oral study of aspirin, phenacetin and caffeine in C57BL/6 mice. Drug Chem. Toxicol. 1980; 3: 135
  • Murray G., Wyllie R. G., Hill G. S., Ramsden P. W., Heptinstall R. H. Experimental papillary necrosis of the kidney. I. Morphology and functional data. Am. J. Pathol. 1972; 67: 285
  • Bach P. H., Grasso P., Molland E. A., Bridges J. W. Changes in the medullary glycosaminoglycan during the development of 2-bromoethanamine hydrobromide-induced renal papillary necrosis. Toxicol. Appl. Pharmacol. 1983; 69: 333
  • Hardy T. L. N-Phenylanthranilic acid: an agent for inducing and studying renal papillary necrosis in the rat. Br. J. Exp. Pathol. 1970; 51: 348
  • Hardy T. L. Partial renal papillectomy and the study of drug induced renal papillary necrosis in the rat. Br. J. Exp. Pathol. 1970; 51: 591
  • Hardy T. L. Experimental surgery in the evaluation of drug induced renal toxicity in the rat with particular reference to diphenylamine. Proc. Eur. Soc. Study Drug Toxic. 1974; 15: 337
  • Hardy T. L., Bach P. H. The effect of N-phenylanthranilic acid-induced renal papillary necrosis on urinary acidification and renal electrolyte handling. Toxicol. Appl. Pharmacol. 1984; 75: 265
  • Powell C. J., Bach P. H., Bridges J. W. 1983, unpublished data
  • Rowe J. S., Carless J. E. Investigations on thein vitro dose-related metabolism of indomethacin in four laboratory species. Eur. J. Drug Metab. Pharmacokin 1982; 7: 159
  • Hart S. J., Calder I. C., Tange J. D. The metabolism and toxicity of paracetamol in Sprague-Dawley and Wistar rats. Eur. J. Drug. Metab. Pharmacokin 1982; 7: 203
  • Kaump D. H. Pharmacology of the fenamates. II. Toxicology in animals. Ann. Physiol. Med. Suppl. 1966; 1: 16
  • Davies D. J., Kennedy A., Saluja P. G. Significance of the urinary excretion of cells after experimental medullary necrosis. Ann. Rheum. Dis. 1968; 27: 130
  • Kennedy A., Saluga P. G. Urinary cytology in experimental toxic renal injury. Ann. Rheum. Dis. 1970; 29: 546
  • Ellis B. G., Price R. G., Topham J. C. The effect of papillary damage by ethyleneimine on kidney function and some urinary enzymes in the dog. Chem. Biol. Interact. 1973; 7: 131
  • Ellis B. G., Price R. G. Urinary enzyme excretion during renal papillary necrosis induced in rats with ethyleneimine. Chem. Biol. Interact. 1975; 11: 473
  • Sabatini S., Mehta P. K., Baranowski R. L., Westenfelder C., Arruda J. A. L., Kurtzman N. A. Role of medullary collection ducts (MCD) in electrolyte transport, as assessed by a model of medullary necrosis. Clin. Res. 1978; 26: 475
  • Sabatini S., Mehta P. K., Julka N. K., Westenfelder C., Arruda J. A. L. Experimental papillary necrosis; functional enzymatic and morphological studies. Clin. Res. 1978; 26: 692
  • Arruda J. A. L., Sabatini S., Mehta P. K., Sodhi B., Baranowski R. Functional characterization of drug-induced experimental papillary necrosis. Kidney Int. 1979; 15: 264
  • Sabatini S., Mehta P. K., Hayes S., Kurtzman N. A., Arruda J. A. L. Drug-induced papillary necrosis: electrolyte excretion and nephron heterogeneity. Am. J. Physiol. 1981; 241: F14
  • Sabatini S., Alla V., Wilson A., Cruz-Soto M., de White A., Kurtzman N. A., Arruda J. A. L. The effects of chronic papillary necrosis on acid excretion. Pfluegers Arch. 1982; 393: 262
  • Risdon R. A., Berry C. L., Chrispin A. R. Urographic changes in acute papillary necrosis in the rat. Br. Med. J. 1970; 3: 263
  • Sherwood T., Swales J. D., Tange J. D. Experimental renal papillary necrosis: progressive changes on intravenous urography. Invest. Radiol. 1971; 6: 239
  • Mudge G. H. Nephrotoxicity of urographic radiocontrast drugs. Kidney Int. 1980; 18: 540
  • Mudge G. H. Nephrotoxicity associated with the use of radiological contrast drugs. Nephrotoxicity: Assessment and Pathogenesis, P. H. Bach, F. W. Bonner, J. W. Bridges, E. A. Lock. John Wiley & Sons, ChichesterEngland 1982; 460
  • Axelsen R. A. Spontaneous renal papillary necrosis in the Gunn rat. Pathology 1973; 5: 43
  • Axelsen R. A. Experimental renal papillary necrosis in the rat: the selective vulnerability of medullary structures to injury. Virchows Arch. A 1978; 381: 79
  • Axelsen R. A. Healed experimental renal papillary necrosis and cortical scarring in the rat from 2-bromoethylamine hydrobromide. Virchows Arch. A 1978; 381: 63
  • Henry M. A., Sweet R. S., Tange J. D. A new reproducible experimental model of analgesic nephropathy. J. Pathol. 1983; 139: 23
  • Gorer P. A. Renal lesions found in pure lines of mice. J. Pathol. Bacteriol. 1940; 50: 25
  • Dunn T. B. Relationship of amyloid infiltration and renal disease in mice. J. Natl. Cancer Inst. 1944; 5: 17
  • Cornelius E. A. Amyloidosis and renal papillary necrosis in male hybrid mice. Am. J. Pathol. 1970; 59: 317
  • Schmid R., Axelrod J., Hammaker L., Swarm R. L. Congenital jaundice in rats: due to a defect in glucuronide formation. J. Clin. Invest. 1958; 37: 1123
  • Blanc W. A., Johnson L. Studies on kernicterus. J. Neuropathol. Exp. Neurol. 1959; 18: 165
  • Watanabe S., Sakaguchi H. Renal papillary necrosis in the newborn – report of three cases with autopsy findings and review of the literature. Acta Pathol. Jpn. 1969; 19: 419
  • Laczko L., Gautier A., Gardiol D. Etude du pigment bilirubinique non conjugue. Structure et ultrastructure de le papille renale du rat Gunn. Pathol. Eur. 1972; 7: 71
  • Briggs D., Calder I., Woods R., Tange J. The influence of metabolic variation on analgesic nephrotoxicity. Experiments with the Gunn rat. Pathology 1982; 14: 349
  • Gomba Sz., Gardiol D., Gautier A. Pathomorphology of unconjugated hyperbilirubinaemia. I. “Bilirubin nephropathy” of Gunn rats. Pathol. Eur. 1973; 8: 61
  • Henry M., Tange J. D. The genesis and ultrastructural appearance of spontaneous renal lesion in the homozygous Gunn rat. Pathology 1982; 14: 355
  • Odell G. B., Natzschka J. C., Storey G. N. B. Bilirubin nephropathy in the Gunn strain of rat. Am. J. Physiol. 1967; 212: 931
  • Odell G. B., Bolen J. L., Poland R. L., Seungdamrong S., Cukier J. O. Protection from bilirubin nephropathy in jaundiced Gunn rats. Gastroenterology 1974; 66: 1218
  • Call N. B., Tisher C. C. The urinary concentrating defect in the Gunn strain of rat. Role of bilirubin. J. Clin. Invest. 1975; 55: 319
  • Martinez-Maldonado M., Suki W. N., Schenker S. Nature of the urinary concentrating defect in the Gunn strain of rat. Am. J. Physiol. 1969; 216: 1386
  • Lester R., Hammaker L., Schmid R. A new therapeutic approach to unconjugated hyperbilirubinaemia. Lancet 1962; 2: 1257
  • Axelsen R. A. The induction of renal papillary necrosis in Gunn rats by analgesics and analgesic mixtures. Br. J. Exp. Pathol. 1975; 56: 92
  • Axelsen R. A., Burry A. F. Bilirubin-associated renal papillary necrosis in the homozygous Gunn rat: light- and electron-microscopic observations. J. Pathol. 1976; 120: 165
  • Axelsen R. A. Nephrotoxicity of mild analgesics in the Gunn strain of rat. Br. J. Clin. Pharmacol. 1980; 10: 309S
  • Axelsen R. A., Burry A. F. Papillary necrosis in the Gunn rat: rapid induction by analgesics. Pathology 1972; 4: 225
  • Harper G. S., Axelsen R. A. Salicylate-induced renal papillary necrosis in the Gunn rat. The role of bilirubin. Lab. Invest. 1982; 47: 258
  • Molland E. A. Aspirin damage in the rat kidney in the intact animal and after unilateral nephrectomy. J. Pathol. 1976; 120: 43
  • Henry M. A., Tange J. D. Ultrastructural appearances of acute renal papillary lesions induced by aspirin. J. Pathol. 1983; 139: 57
  • Wold J. S., Joost R. R., Owen N. V. Nephrotoxicity of cephaloridine in newborn rabbits: role of the renal anionic transport system. J. Pharmacol. Exp. Ther. 1977; 201: 788
  • Smith S. E., Rawlins M. D. Variability in Human Drug Response. Butterworths, London 1973
  • Oie S., Levy G. Effect of salicylic acid on pharmacokinetics of free and plasma protein-bound bilirubin in experimental unconjugated hyperbilirubinemia. J. Pharm. Sci. 1979; 68: 1
  • Schmid R., Axelrod L., Hammaker L., Swarm R. L. Congenital jaundice in rats due to a defect in glucuronide formation. J. Clin. Invest. 1958; 37: 1123
  • Calder I. C., Funder C. C., Green C. R., Ham K. N., Tange J. D. Comparative nephrotoxicity of aspirin and phenacetin derivatives. Br. Med. J. 1971; 4: 518
  • Emslie K. R., Calder I. C., Hart S. J., Tange J. D. Metabolism of paracetamol by the isolated perfused kidney of the homozygous Gunn rat. Xenobiotica 1982; 12: 77
  • Burr G. O., Burr M. M. A new deficiency disease produced by the rigid exclusion of fat from the diet. J. Biol. Chem. 1929; 82: 345
  • Burr G. O., Burr M. M. The nature and role of the fatty acids essential in nutrition. J. Biol. Chem. 1930; 86: 587
  • Borland V. G., Jackson C. M. Effects of a fat-free diet on the structure of the kidney in rats. Arch. Pathol. 1931; 11: 687
  • Molland E. A. Renal papillary necrosis produced by long-term fat-free diet. Nephrotoxicity: Pathogenesis and Assessment, P. H. Bach, F. W. Bonner, J. W. Bridges, E. A. Lock. John Wiley & Sons, ChichesterEngland 1982; 200
  • McAmis A. J., Anderson W. E., Mendel L. B. Growth of rats on ‘fat-free’ diets. J. Biol. Chem. 1929; 82: 247
  • Muirhead E. E., Vanatta J., Grollman A. Papillary necrosis of the kidney. JAMA 1950; 142: 627
  • Sheehan H. L., Davis J. C. Renal ischaemia with good reflow. J. Pathol. Bacteriol. 1959; 78: 351
  • Edmonson H. A., Martin H. E., Evans N. G. Necrosis of renal papillae and acute pyelonephritis in diabetes mellitus. Arch. Int. Med. 1947; 79: 148
  • Dzlukas L. J., Sterzel R. B., Hodson C. J., Hoyer J. R. Renal localization of Tamm-Horsfall protein in unilateral obstructive uropathy in rats. Lab. Invest. 1982; 47: 185
  • Beswick I. P., Schatzki P. F. Experimental renal papillary necrosis. Arch. Pathol. 1960; 69: 733
  • Sheehan H. L., Davis J. C. Experimental hydronephrosis. Arch. Pathol. 1959; 68: 185
  • Baum M., Stirling G. A., Dawson J. L. Further study into obstructive jaundice and ischaemic renal damage. Br. Med. J. 1969; 2: 229
  • Davies D. J. Renal Medullary Necrosis. M.D. thesis, University of Liverpool, England 1967
  • Torhorst J., de Rougemont D., Brunner F. P., Thiel G. Morphology of the renal medulla in ischemic acute renal failure in the rat. Nephron 1982; 31: 296
  • Wolgast M., Karlberg L., Kallskog O., Norlen B.J., Nygren K., Ojteg G. Hemodynamic alterations in ischaemic acute renal failure. Nephron 1982; 31: 301
  • Mason J., Thiel G. Workshop on the role of renal medullary circulation in the pathogenesis of acute renal failure. Symposium on medullary circulation in acute renal failure. Nephron 1982; 31: 289
  • Thiel G., de Rougemont D., Kriz W., Mason J., Thorhorst J., Wolgast M. The role of reduced medullary perfusion in the genesis of acute ischemic renal failure. Nephron 1982; 31: 321
  • Patrick R. L., Kroe D. J., Klavins J. V. Renal papillary necrosis induced by heterologous serum. Arch. Pathol. 1964; 78: 108
  • Kroe D. J., Klavins J. V. Renal and extra-renal lesions induced by heterologous serum. Sequence of changes following administration of human serum to rats. Arch. Pathol. 1965; 80: 345
  • Wizgird J. P., French S. W., Coulson W. Pathogenesis of serum-induced papillary necrosis. Arch. Pathol. 1965; 79: 57
  • Ljungqvist A., Richardson J. Studies on the pathogenesis of serum-induced renal papillary necrosis in the rat. I. Stereo-microangiographic and histologic examinations of the renal lesion in nonheparinized and heparinized animals and in animals given diuretic drugs. Lab. Invest. 1966; 15: 1395
  • Gullbring B., Ljungqvist A., Richardson J. Studies on the pathogenesis of serum-induced renal papillary necrosis in the rat. II. The effect of heating human serum and the localization of human protein in the affected kidneys. Lab. Invest. 1966; 15: 1486
  • Ljungqvist A., Osvaldo-Decima L., Richardson J. Studies on the pathogenesis of serum-induced renal papillary necrosis in the rat. III. The early morphologic changes studied by light and electron microscopy. Lab. Invest. 1967; 17: 447
  • Fedoroff S., Doerr J. Effect of human blood serum on tissue cultures. III. A natural cytotoxic system in human blood serum. J. Natl. Cancer Inst. 1962; 29: 331
  • Rossmann P., Matousovic K. The production of lesions in the rabbit kidney by xenoperfusion with fresh human blood. Virchows Arch. A 1979; 382: 95
  • Rudofsky U. H., Dilwith R. L., Tung K. S. K. Susceptibility differences of inbred mice to induction of autoimmune renal tubulointerstitial lesions. Lab. Invest 1980; 43: 463
  • Hardy T. L. 1978, unpublished data
  • Calder I. C., Funder C. C., Green C. R., Ham K. N., Tange J. D. Nephrotoxic lesions from 5-amino salicyclic acid. Br. Med. J. 1972; 1: 152
  • Campieri M., Lanfranchi G. A., Bazzocchi G., Brignola C., Sarti F., Franzin G., Battocchia A., Labo G., Dal Monte P. R. Treatment of ulcerative colitis with high-dose 5-aminosalicylic acid enemas. Lancet 1981; 2: 270
  • Peppercorn M. A., Goldmann P. Distribution studies of salicylazosulfapyridine and its metabolites. Gastroenterology 1973; 64: 240
  • Berry C. N., Hoult J. R. S., Peers S. H., Agback H. Inhibition of prostaglandin 15-hydroxy-dehydrogenase by sulphasalazine and a novel series of potent analogues. Biochem. Pharmacol. 1983; 32: 2863
  • Green C. R., Ham K. N., Tange J. D. Kidney lesions induced in rats by p-aminophenol. Br. Med. J. 1969; 1: 162
  • Carpenter H. M., Mudge G. H. Acetaminophen nephrotoxicity: studies on renal acetylation and deacetylation. J. Pharmacol. Exp. Ther. 1981; 218: 161
  • Gemborys M. W., Mudge G. H. Formation and disposition of the minor metabolites of acetaminophen in the hamster. Drug Metab. Dispos. 1981; 9: 340
  • Newton J. F., Kuo C.H., Gemborys M. W., Mudge G. H., Hook J. B. Nephrotoxicity of p-aminophenol, a metabolite of acetaminophen, in the Fischer 344 rat. Toxicol. Appl. Pharmacol. 1982; 65: 336
  • Newton J. F., Yoshimoto M., Bernstein J., Rush G. F., Hook J. B. Acetaminophen nephrotoxicity in the rat. I. Strain differences in nephrotoxicity and metabolism. Toxicol. Appl. Pharmacol. 1983; 69: 291
  • Newton J. F., Yoshimoto M., Bernstein J., Rush G. F., Hook J. B. Acetaminophen nephrotoxicity in the rat. II. Strain differences in nephrotoxicity and metabolism of p-aminophenol, a metabolite of acetaminophen. Toxicol. Appl. Pharmacol. 1983; 69: 307
  • Crowe C. A., Yong A. C., Calder I. C., Ham K. N., Tange J. D. The nephrotoxicity of p-aminophenol. I. The effect on microsomal cytochromes, glutathione and covalent binding in kidney and liver. Chem. Biol. Interact. 1979; 27: 235
  • Calder I. C., Yong A. C., Woods R. A., Crowe C. A., Ham K. N., Tange J. D. The nephrotoxicity of p-aminophenol. II. The effect of metabolic inhibitors and inducers. Chem. Biol. Interact. 1979; 27: 245
  • White J., Mori-Chavez P. Acute necrotizing renal papillitis experimentally produced in rats fed mono-N-methylaniline. J. Natl. Cancer Inst. 1952; 12: 777
  • Rhens J. D'une necrose typique de la papile renale determinee par la tetrahydroquinoleine et certains de ses derives. Arch. Int. Pharmacodyn. Ther. 1901; 8: 199
  • Easley J. R., Holland J. M., Gipson L. C., Whitaker M. J. Renal toxicity of middle distillates of shale oil and petroleum in mice. Toxicol. Appl. Pharmacol. 1982; 65: 84
  • Bruckner J. V., Khanna K. L., Cornish H. H. Polychlorinated biphenyl-induced alteration of biologic parameters in the rat. Toxicol. Appl. Pharmacol. 1974; 28: 189
  • Levaditi C. Experimentelle untersuchungen uber die Nekrose der Nieranpapille. Arch. Int. Pharmacodyn. Ther. 1901; 8: 45
  • Oka A. Zur Histologie der Vinylaminnephritis. Virchows Arch. 1913; 214: 149
  • Mandel E. E., Popper H. Experimental medullary necrosis of the kidney. Arch. Pathol. 1951; 52: 1
  • Wright G. J., Rowe V. K. Ethyleneimine: studies of the distribution and metabolism in the rat using carbon-14. Toxicol. Appl. Pharmacol. 1967; 11: 575
  • Davies D. J. Changes in the renal cortex following experimental medullary necrosis. Arch. Pathol. 1968; 86: 377
  • Davies D. J., Kennedy A., Saluja P. G. Significance of the urinary excretion of cells after experimental medullary necrosis. Ann. Rheum. Dis. 1968; 27: 130
  • Ham K. N., Tange J. D. Some experimental observations relating to the pathogenesis of renal papillary necrosis. Aust. Ann. Med. 1969; 18: 199
  • Davies D. J. The structural changes in the kidney and urinary tract caused by ethyleneimine (“viny-lamine”). J. Pathol. 1969; 97: 695
  • Davies D. J. The early changes produced in the rabbit renal medulla by ethyleneimine: electronmicroscope and circulatory studies. J. Pathol. 1970; 101: 329
  • Swales J. D., Funder C. C., Tange J. D. Healed experimental renal papillary necrosis. J. Pathol. 1973; 109: 209
  • Fuwa M., Waugh D. Experimental medullary necrosis: effects of diuresis and anti-diuresis. Arch. Pathol. 1968; 85: 404
  • Hill G. S., Wyllie R. G., Miller M., Heptinstall R. H. Experimental papillary necrosis of the kidney. II. Electron microscopic and histochemical studies. Am. J. Pathol. 1972; 68: 213
  • Shimamura T. Drug induced renal medullary necrosis. I. Structural alterations of renal medulla. Arch. Pathol. 1972; 94: 406
  • Wyllie R. G., Hill G. S., Murray G., Ramsden P. W., Heptinstall R. H. Experimental papillary necrosis of the kidney. III. Effects of reserpine and other pharmacological agents on the lesion. Am. J. Pathol. 1972; 68: 235
  • Thiele E. H. Anin vivo pyelonephritis assay for screening therapeutic agents. J. Antibiot. 1974; 27: 31
  • Shimamura T., Aogaichi M., Liu C. Y. Drug-induced renal medullary necrosis. II. Mode of calcification in the kidney. Exp. Mol. Pathol. 1974; 20: 109
  • Heptinstall R. H., Salyer D. C., Salyer W. R. Experimental hypertension. Am. J. Pathol. 1975; 78: 297
  • Cuppage F. E., Tate A. Repair of the rat kidney following papillary necrosis produced by bromoethylamine hydrobromide. Lab. Invest. 1975; 31: 593
  • Shimamura T. Drug-induced renal medullary necrosis. Exp. Mol. Pathol. 1975; 22: 176
  • Murray G., von Stowasser V. Glomerular lesions in experimental renal papillary necrosis. Br. J. Exp. Pathol. 1976; 57: 23
  • Shimamura T., Bonk K. Repair of the injured renal papillary tissue in rats. Invest. Urol. 1976; 14: 111
  • Shimamura T. Drug-induced renal medullary necrosis. IV. Effects on the urinary sodium output and systemic blood pressure. Exp. Mol. Pathol. 1976; 25: 1
  • Mehta P. K., Sodhi B., Arruda J. A. L., Kurtzman N. A. Functional studies in experimental medullary necrosis (MN). Kidney Int. 1977; 12: 530
  • Reineck H. J., Parma R., Barnes J. L., Osgood R. W. Nephron heterogeneity in renal excretion of sodium and potassium in the rat. Am. J. Physiol. 1980; 239: 187
  • Bach P. H., Christian R., Baker J., Bridges J. W. The metabolism of 2-bromo-[1-14C]ethan-1-amine (BEA): a model compound for inducing renal papillary necrosis (RPN). Mechanisms of Toxicity and Hazard Evaluation, B. Holmstedt, R. Lauwerys, M. Mercier, M. Roberfroid. Elsevier, Amsterdam 1980; 553
  • Sabatini S., Subbarayuda K., Kurtzman N. A., Arruda J. A. L. The pathogenesis of drug induced papillary necrosis (PN): the role of urinary concentration. Kidney Int. 1981; 19: 213
  • Cuttino J. T., Goss F. U., Clark R. L., Marr M. C. Experimental renal papillary necrosis in rats: microangiographic and tubular micropuncture injection studies. Invest. Radiol. 1981; 16: 107
  • Vanholder R., Lameire N., Eeckhaut W., Ringoir S. Renal function studies in an experimental model of papillary necrosis in the rat. Arch. Int. Physiol. Biochim. 1981; 89: 63
  • Bing R. F., Russell G. I., Swales J. D., Thurston H., Fletcher A. Chemical renal medullectomy: effect upon reversal of two-kidney one-clip hypertension in the rat. Clin. Sci. 1981; 61: 335s
  • Gobe G. C., Axelsen R. A. Localization of medullary functional abnormalities in experimental papillary necrosis. Pathology 1982; 14: 383
  • Burnett R. 1982, unpublished data
  • Sabatini S., Koppera S., Manaligod J., Arruda J. A. L., Kurtzman N. A. Role of urinary concentrating ability in the generation of toxic papillary necrosis. Kidney Int. 1983; 23: 705
  • Bing R. F., Russell G. I., Thurston H., Swales J. D. 1983, unpublished data
  • Bing R. F., Russell G. I., Thurston H., Swales J. D., Godfrey N., Lazarus Y., Jackson J. Chemical renal medullectomy: effect upon urinary prostaglandin E2 plasma renin and sodium balance, and response to variations in sodium intake and in relation to blood pressure. Hypertension 1983; 5: 951
  • Stonard M. J. 1983, unpublished data
  • Wirdnam P. K., StDawnay A. J. B., Bach P. H. 1981, unpublished data
  • Scholey D. J., Bach P. H. 1983, unpublished data
  • Lu Q. H., Bach P. H. 1983, unpublished data
  • Ninan T., Wilson G. B. Chromosome breakage by ethylenimines and related compounds. Genetica 1969; 40: 103
  • Dermer O. C., Ham G. E. Ethyleneimine and Other Aziridines. Academic Press, New York 1969
  • Jackson H., James R. M. V. The effect of certain ethyleneimines on renal function. Br. J. Pharmacol. 1963; 21: 581
  • Jackson H., James R. M. V. Metabolic studies with certain ethyleneimine derivatives in relation to diuresis. Br. J. Pharmacol. 1965; 25: 223
  • Jones A. R. The metabolism of biological alkylating agents. Drug Metab. Rev. 1973; 2: 71
  • James S. P., Pue M. A., Richards D. H. Metabolism of 1,3-dibromopropane. Toxicol. Lett. 1981; 8: 7
  • Raftery M. A., Cole R. D. Tryptic cleavage at cysteinyl peptide bonds. Biochem. Biophys. Res. Commun. 1963; 10: 467
  • Boutwell R. K. The function and mechanism of promoters of carcinogenesis. CRC Crit. Rev. Toxicol. 1974; 2: 419
  • Cohen S. M., Greenfield R. E., Ellwein L. B. Multistage carcinogenesis in the urinary bladder. Environ. Health Perspect. 1983; 49: 209
  • Melicow M. M. Tumours of the urinary drainage tract: urothelial tumors. J. Urol. 1945; 54: 186
  • Newman J., Hicks R. M. Surface ultrastructure of the epithelia lining the normal human lower urinary tract. Br. J. Exp. Pathol. 1981; 62: 232
  • Johansson S., Angervall L. Urothelial hyperplasia of the renal papillae in female Sprague-Dawley rats induced by long term feeding of phenacetin. Acta Pathol. Microbiol. Scand. Sect. A 1976; 84: 353
  • Johansson S., Angervall L. Urothelial changes of the renal papillae in Sprague-Dawley rats induced by long term feeding of phenacetin. Acta Pathol. Microbiol. Scand. Sect. A 1976; 84: 375
  • Isaka H., Yoshi H., Otsuji A., Koike M., Nagai Y., Koura M., Sugiyasu K., Kanabayashi T. Tumors of Spague-Dawley rats induced by long-term feeding of phenacetin. Gann 1979; 70: 29
  • Nakanishi K., Kurata Y., Oshima M., Fukushima S., Ito N. Carcinogenicity of phenacetin: long-term feeding study in B6C3F1 mice. Int. J. Cancer 1982; 29: 439
  • Johansson S. L. Carcinogenicity of analgesics: long-term treatment of Sprague-Dawley rats with phenacetin, phenazone, caffeine and paracetamol (acetaminophen). Int. J. Cancer 1981; 27: 521
  • Bioassay of a Mixture of Aspirin, Phenacetin, and Caffeine for Possible Carcinogenicity. Tech. Rep. Ser. No. 67, Carcinogenesis, National Cancer Institute, Washington, DC 1978
  • Nakanishi K., Fukushima S., Shibata M., Shirai T., Ogiso T., Ito N. Effect of phenacetin and caffeine on the urinary bladder of rats treated with N-butyl-N-(4-hydroxybutyl) nitrosamine. Gann 1978; 69: 395
  • Vaught J. B., King C. M. Phenacetin studies. Science 1979; 206: 637
  • Takayama S., Kuwabara N. Long-term study on the effect of caffeine in Wistar rats. Gann 1982; 73: 365
  • Bryan G. T. The role of urinary tryptophan metabolites in the etiology of bladder cancer. Am. J. Clin. Nutr. 1971; 24: 814
  • Cohen S. M., Arai M., Jacobs J. B., Friedell G. H. Promoting effect of saccharin and dl-tryptophan in urinary bladder carcinogenesis. Cancer Res. 1979; 39: 1207
  • McArthur J. N., Dawkins P. D., Smith M. J. H. The displacement of l-tryptophan dipeptides from bovine albuminin vitro by antirheumatic drugs. J. Pharm. Phamol. 1971; 23: 393
  • Smith H. G., Lakatos C. Effects of acetylsalicylic acid on serum protein binding and metabolism of tryptophan in man. J. Pharm. Pharmacol. 1971; 23: 180
  • Rowland R. G., Henneberry M. O., Oyasu R., Grayhack J. T. Effects of urine and continued exposure to carcinogen on progression of early neoplastic urinary bladder lesions. Cancer Res. 1980; 40: 4524
  • Oyasu R., Hirao Y., Izumi K. Enhancement by urine of urinary bladder carcinogenesis. Cancer Res. 1981; 41: 478
  • Babaya K., Miyata Y., Chmiel J. S., Oyasu R. Effects of rat urine fractionated by molecular weight on urinary bladder carcinogenesis. Cancer Res. 1982; 42: 15
  • Hirao Y., Izumi K., Oyasu R. The effect of normal rat urine on mucosal regeneration in heterotopic urinary bladder. Lab. Invest. 1980; 42: 76
  • Izumi K., Hirao Y., Hopp L., Oyasu R. In vitro induction of ornithine decarboxylase in urinary bladder carcinoma cells. Cancer Res. 1981; 41: 405
  • Wood J. H., Leonard T. W. Kinetic implications of drug resorption from the bladder. Drug Metab, Rev. 1983; 14: 407
  • Melicow M. M. The urothelium: a battleground for oncogenesis. J. Urol. 1978; 120: 43
  • Bodenstab W., Kaufman J.Lowell Parsons C. Inactivation of antiadherence effect of bladder surface glycosaminoglycan by a complete urinary carcinogen (N-methyl-N-nitrosourea). J. Urol. 1983; 129: 200
  • Webb A. J., Dawson-Edwards P. Non-malignant retroperitoneal fibrosis. Br. J. Surg. 1967; 54: 508
  • Reinking L. N., Schmidt-Nielsen B. Peristaltic flow of urine in the renal papillary collecting ducts of hamsters. Kidney Int. 1981; 20: 55
  • Schmidt-Nielsen B., Churchill M., Reinking L. N. Occurrence of renal pelvic refluxes during rising urine flow rate in rats and hamsters. Kidney Int. 1980; 18: 419
  • Constatinou C. E. Renal pelvic pacemaker control of ureteral peristaltic rate. Am. J. Physiol. 1974; 266: 1413
  • Borda E., Chaud M., Gutnisky R., Contreras Ortiz N., Gimeno M. F., Gimeno A. L. Relationship between prostaglandins and estrogens on the motility of isolated rings from the rat urinary bladder. J. Urol. 1983; 129: 1250
  • Bokelman D. L., Bagdon W. J., Mattis P. A., Stonier P. F. Strain-dependent renal toxicology of a nonsteroidal antiinflammatory agent. Toxicol. Appl. Pharmacol. 1971; 19: 111
  • Lalich J. J., Paik W. C. W., Pradhan B. Epithelial hyperplasia in the renal papilla of rats. Induction in animals fed excess sodium chloride. Arch. Pathol. 1974; 97: 29
  • Murasaki G., Greenfield R. E., Cohen S. M. Alterations in the rat kidney associated with sodium saccharin feeding. Toxicol. Lett. 1982; 12: 251
  • Erturk E., Price J. M., Morris J. E., Cohen S., Leith R. S., Von Esch A. M., Crovetti A. J. The production of carcinoma of the urinary bladder by feeding N-[4-(5-nitro-2-furyl)-2-thiazolyl] formamide. Cancer Res. 1967; 27: 1998
  • Erturk E., Cohen S. M., Price J. M., Bryan G. T. Pathogenesis, histology and transplantability of urinary bladder carcinomas induced in albino rats by oral administration of N-[4-(5-nitro-2-furyl)-2-thiazoly] formamide. Cancer Res. 1969; 29: 2219
  • Anderstrom C., Johansson S. L., von Schultz L. The influence of phenacetin or mechanical perforation on the development of renal pelvic and urinary bladder turnours in FANFT-induced urinary tract carcinogenesis. Acta Pathol. Microbiol. Immunol. Scand. Sect. A 1983; 91: 373
  • Van Schultz L. 1984, unpublished data
  • Mudge G. H. Pathogenesis of nephrotoxicity: pharmacological principles. Renal Heterogeneity and Target Cell Toxicity, P. H. Bach, E. A. Lock. John Wiley & Sons, ChichesterEngland 1985; 1
  • Duggin G. G., Mudge G. H. Renal tubular transport of paracetamol and its conjugates in the dog. Br. J. Pharmacol. 1975; 54: 359
  • Duggin G. G., Mudge G. H. Analgesic nephropathy: renal distribution of acetaminophen and its conjugates. J. Pharmacol. Exp. Ther. 1976; 199: 1
  • Duggin G. G., Mudge G. H. Phenacetin: renal tubular transport and intrarenal distribution in the dog. J. Pharmacol. Exp. Ther. 1976; 199: 10
  • Gault M. H. Intra-renal gradients of radioactive acetylsalicylic acid and inulin. Clin. Res. 1971; 19: 808
  • Molland E. A. 1978, unpublished data
  • Brown D. M., Hardy T. L. Short-term study of the effect of phenacetin, phenazone and amidopyrine on the rat kidney. Br. J. Pharmacol. 1968; 32: 17
  • Booth A. N., Ambrose A. M., DeEds F., Cox A. J. The reversible nephrotoxic effects of biphenyl. Toxicol. Appl. Pharmacol. 1961; 3: 560
  • Angervall L., Lehmann L., Bengtsson U. The renal concentrating capacity in albino rats after long-term consumption of phenacetin, NAPA (N-acetyl-p-aminophenol) and acetylsalicylic acid. Acta Med. Scand. 1964; 175: 155
  • Angervall L., Bengtsson U. Impairment of renal concentrating capacity in Albino rats induced by phenacetin and acetylsalicylic acid. Acta Pharmacol. Toxicol. 1968; 26: 105
  • Dawson J. L., Stirling G. A. Protective effect of mannitol on anoxic jaundiced kidneys: a histological study. Arch. Pathol. 1964; 78: 254
  • Sagone A. L., Greenwald J., Kraut E. H., Bianchine J., Singh D. Glucose: a role as a free radical scavenger in biological systems. J. Lab. Clin. Med. 1983; 101: 97
  • Said R., Marin P., Anicama H., Quintanilla A., Levin M. L. Effect of mannitol on acute amphotericin B nephrotoxicity. Res. Exp. Med. 1980; 177: 85
  • Newman R. A., Weinstock L. B., Gump D. W., Hacker M. P., Yates J. W. Effect of osmotic diuresis on gentamicin-induced nephrotoxicity in rats. Arch. Toxicol. 1980; 45: 213
  • Teixeira R. B., Kelley J., Alpert H., Pardo V., Vaamonde C. A. Complete protection from gentamicin-induced acute renal failure in the diabetes mellitus rat. Kidney Int. 1982; 21: 600
  • Gellai M., Edwards B. R., Valtin H. Nembutal and inactin anaesthetic depress glomerular filtration rate and renal blood flow by direct action on the kidney. Kidney Int. 1979; 16: 814
  • Furman K. I., Kundig H., Lewin J. R. Experimental paracetamol nephropathy and pyelonephritis in rats. Clin. Nephrol. 1981; 16: 271
  • Robert A. Cytoprotection by prostaglandins. Gastroenterology 1979; 77: 761
  • Bray M. A. Prostaglandins: fine tuning the immune system?. Immunol. Today 1980; 1: 65
  • Hoult J. R. S., Moore P. K. Effects of sulphasalazine and its metabolites on prostaglandin synthesis, inactivation and actions on smooth muscle. Br. J. Pharmacol. 1980; 68: 719
  • Sircar J. C., Schwender C. F., Johnson E. A. Soybean lipoxygenase inhibition by nonsteroidal anti-inflammatory drugs. Prostaglandins 1983; 25: 393
  • Danon A., Leibson V., Assouline G. Effects of aspirin, indomethacin, flufenamic acid and paracetamol on prostaglandin output from rat stomach and renal papilla in-vitro and ex-vivo. J. Pharm. Pharmacol. 1983; 35: 576
  • Matsuda K., Ohnishi K., Misaka E., Yamazaki M. Decrease of urinary prostaglandin E2 and prostaglandin E2α excretion by nonsteroidal anti-inflammatory drugs in rats. Relationship to anti-inflammatory activity. Biochem. Pharmacol. 1983; 32: 1347
  • Patrono C., Wennmalm A., Ciabattoni G., Nowak J., Pugliese F., Cinotti G. A. Evidence for an extra-renal origin of urinary prostaglandin E2 in healthy men. Prostaglandins 1978; 18: 623
  • Cagen L. M., Kauker M. L. Metabolism of intratubular prostaglandin E2 in the rat kidney. Biochem. Pharmacol. 1983; 32: 3665
  • Nugteren D. H., Van Evert W. C., Soeting W. J., Spuy J. H. Effect of different amounts of linoleic acid in the diet on the excretion of urinary prostaglandin metabolites in the rat. Adv. Prostaglandin Thromb. Res. 1980; 8: 1793
  • Dunham E. W., Balasingam M., Privett O. S., Nickell E. C. Effects of essential fatty acid deficiency on prostaglandin synthesis and fatty acid composition in rat renal medulla. Lipids 1978; 13: 892
  • Kaa E. In vitro biosynthesis of prostaglandin E2 by kidney medulla of essential fatty acid deficient rats. Lipids 1976; 11: 693
  • Sakr H. M., Dunham E. W. Enhanced renal vasoconstriction in rats fed essential fatty acid-deficient diet. Am. J. Physiol. 1982; 243: H61
  • Flick P. K. Rapid changes in rat liver fatty acid composition during fat-free and polyunsaturated fat feeding. Nutr. Rep. Int. 1981; 24: 667
  • Mathias M. M., Dupont J. The relationship of dietary fats to prostaglandin biosynthesis. Lipids 1979; 14: 247
  • Honn K. V., Bockman R. S., Marnett L. J. Prostaglandins and cancer: a review of tumour initiation through tumour metastasis. Prostaglandins 1981; 21: 833
  • Hassid A., Levine L. Induction of fatty acid cyclooxygenase activity in canine kidney cells (MDCK) by benzo(a)pyrene. J. Biol. Chem. 1977; 252: 6591
  • Levine L., Hassid A. Effects of phorbol-12,13-diesters on prostaglandin production and phospholipase activity in canine kidney (MDCK) cells. Biochem. Biophys. Res. Commun. 1977; 79: 477
  • Wrighton S. A., Pai J.K., Mueller G. C. Demonstration of two unique metabolites of arachidonic acid from phorbol ester-stimulated bovine lymphocytes. Carcinogenesis 1983; 4: 1247
  • Narisawa T., Satoh M., Sano M., Takahashi T. Inhibition of initiation and promotion by N-methylnitrosourea-induced colon carcinogenesis in rats by non-steroid anti-inflammatory agent indomethacin. Carcinogenesis 1983; 4: 1225
  • Kollmorgan G. M., King M. M., Kosanke S. D., Do C. Influence of dietary fat and indomethacin on the growth of transplantable mammary tumors in rats. Cancer Res. 1983; 43: 4714
  • Davidson W., Bassist L., Shippey W. In vitro effects of aspirin and phenacetin metabolism of dog renal medulla. Clin. Res. 1973; 21: 227
  • Davidson W., Bassist L., Shippey W. Effect of aspirin and phenacetin metabolites on protein synthesis in dog renal medulla. Clin. Res 1973; 21: 683
  • Goldberg M., Myers C. L., Peshel W., McCarron D., Morrison A. B. Mechanism of analgesic abuse nephropathy. J. Clin. Invest. 1971; 50: 37a
  • Crowe C. A., Calder I. C., Madsen N. P., Funder C. C., Green C. R., Ham K. H., Tange J. D. An experimental model of analgesic induced renal damage – some effects of p-aminophenol on rat kidney mitochondria. Xenobiotica 1977; 7: 345
  • Dawson A. G. Preparation and some properties of a suspension of fragmented tubules from rat kidney. Biochem. J. 1972; 130: 525
  • Dawson A. G. Effect of acetylsalicylate on gluconeogenesis in isolated rat kidney tubules. Biochem. Pharmacol. 1975; 24: 1407
  • Porter K. E., Dawson A. G. Inhibition of respiration and gluconeogenesis by paracetamol in rat kidney preparations. Biochem. Pharmacol. 1979; 28: 3057
  • Szinicz L., Weger N., Schneiderham W., Kiese M. Nephrotoxicity of aminophenols: effects of 4-dimethylaminophenol on isolated rat kidney tubules. Arch. Toxicol. 1979; 42: 63
  • Rainsford K. D., Schweitzer A., Brune K. Autoradiographic and biochemical observations on the distribution of non-steroid anti-inflammatory drugs. Arch. Int. Pharmacodyn. 1981; 250: 180
  • Rainsford K. D., Schweitzer A., Brune K. Distribution of the acetyl compared with the salicyl moiety of acetylsalicylic acid. Acetylation of macromolecules in organs wherein side-effects are manifest. Biochem. Pharmacol. 1983; 32: 1301
  • Whitehouse M. W., Bostrom H. The effect of some anti-inflammatory (anti-rheumatic) drugs on the metabolism of connective tissues. Biochem. Pharmacol. 1962; 11: 1175
  • Bostrom H., Berntsen K., Whitehouse M. W. Biochemical properties of anti-inflammatory drugs. II. Some effects on sulphate35-S metabolism in vivo. Biochem. Pharmacol. 1964; 13: 413
  • McKenzie L. S., Horsburgh B. A., Ghosh P., Taylor T. K. F. Effect of anti-inflammatory drugs on sulphated glycosaminoglycan synthesis in aged human articular cartilage. Ann. Rheum. Dis. 1976; 35: 487
  • Dekel S., Falconer J., Francis M. J. O. The effect of anti-inflammatory drugs on glycosaminoglycan sulphation in pig cartilage. Prostaglandins Med. 1980; 4: 133
  • Palmoski M. J., Brandt K. D. Effects of some nonsteroidal antiinflammatory drugs on proteoglycan metabolism and organization in canine articular cartilage. Arthritis Rheum. 1980; 23: 1010
  • Palmoski M. J., Colyer R. A., Brandt K. D. Marked suppression by salicylate of the augmented proteoglycan synthesis in osteoarthritic cartilage. Arthritis Rheum. 1980; 23: 83
  • Ackerman N. R., Jubb S. N., Marlowe S. L. Effects of various anti-inflammatory and antirheumatic agents on the synthesis, secretion and activity of a cartilage proteoglycan-degrading enzyme and other macrophage enzymes. Biochem. Pharmacol. 1981; 30: 2147
  • Comper W. D., DeWitt M., Lowther D. A. Effects of anti-inflammatory drugs on proteoglycan degradation as studied in the rabbit articular cartilage in organ culture. Biochem. Pharmacol. 1981; 30: 459
  • Palmoski M. J., Brandt K. D. Relationship between matrix proteoglycan content and the effects of salicylate and indomethacin on articular cartilage. Arthritis Rheum. 1983; 26: 528
  • Waters W. E., Elwood P. C., Asscher A. W. Community survey of analgesic consumption and kidney function in women. Lancet 1973; 1: 341
  • Vivaldi E. Effect of chronic administration of analgesics on resistant to experimental infection of the urinary tract in rats. Nephron 1968; 5: 202
  • Blackman J. E., Gibson G. R., Lavan J. N., Learoyd H. M., Posens S. Urinary calculi and the consumption of analgesics. Br. Med. J. 1967; 2: 800
  • Lin J. H., Levy G. Renal clearance of inorganic sulfate in rats: effect of acetaminophen-induced depletion of endogenous sulfate. J. Pharm. Sci. 1983; 72: 213
  • Beynen A. C., Buechler K. F., van der Molen A. J., Geelen M. J. H. Inhibition of hepatic lipogenesis by salicylate. Toxicology 1982; 24: 33
  • Wirdnam P. K., Bach P. H. 1981, unpublished data
  • Darmady E. M., McIver A. G. Experimental cystic changes. Renal Pathology. Butterworths, London 1980; 112
  • McCormack K. M., Hook J. B., Gibson J. E. Developmental anomalies of the kidney – a review of normal and aberrant renal development. Toxicology of the Kidney, J. B. Hook. Raven Press, New York 1981; 227
  • Nelson S. D. Metabolic activation and drug toxicity. J. Med. Chem. 1982; 25: 753
  • Bridges J. W., Benford D. J., Hubbard S. A. Mechanisms of toxic injury. Ann. N.Y. Acad. Sci. 1983; 407: 42
  • Smith M. T., Thor H., Orrenius S. The role of lipid peroxidation in the toxicity of foreign compounds to liver cells. Biochem. Pharmacol. 1983; 32: 763
  • Miller E. C. Some current perspectives on chemical carcinogenesis in humans and experimental animals. Cancer Res. 1978; 38: 1479
  • Bus J. S., Gibson J. E. Lipid peroxidation and its role in toxicity. Rev. Biochem. Toxicol. 1979; 1: 125
  • Free Radicals, Lipid Peroxidation and Cancer, D. C. H. McBrien, T. F. Slate. Academic Press, London 1982
  • Nery R. The possible role of N-hydroxylation in the biological effects of phenacetin. Xenobiotica 1971; 1: 339
  • Hinson J. A. Reactive metabolites of phenacetin and acetaminophen: a review. Environ. Health Perspect. 1983; 49: 71
  • Mudge G. H., Gemborys M. W., Duggin G. G. Covalent binding of metabolites of acetaminophen to kidney protein and depletion of renal glutathione. J. Pharmacol. Exp. Ther. 1978; 206: 218
  • Caterson R. J., Duggin G. G., Horvath J. S., Mohandas J., Tiller D. Aspirin, protein transacetylation and inhibition of prostaglandin synthetase in the kidney. Br. J. Pharmacol. 1978; 64: 353
  • Rice J. R., Kissinger P. T. Cooxidation of benzidine by horseradish peroxidase and subsequent formation of possible thioether conjugate of benzidine. Biochem. Biophys. Res. Commun. 1982; 104: 1312
  • Humes J. L., Winter C. A., Sadowski S. J., Kuehl F. A. Multiple sites on prostaglandin cyclooxygenase are determinants in the action of nonsteroidal antiinflammatory agents. Proc. Natl. Acad. Sci., U.S.A. 1981; 78: 2053
  • Nanra R. S., Kincaid-Smith P. Papillary necrosis in rats caused by aspirin and aspirin-containing mixtures. Br. Med. J. 1970; 3: 559
  • Zenser T. V., Mattammal M. B., Herman C. A., Joshi S., Davis B. B. Effect of acetaminophen on prostaglandin E2 and prostaglandin F2α synthesis in the renal inner medulla of rat. Biochim. Biophys. Acta 1978; 542: 486
  • Bruchhausen F. V., Baumann J. Inhibitory actions of desacetylation products of phenacetin and paracetamol on prostaglandin synthetase in neuronal and glial cell lines and rat renal medulla. Life Sci. 1982; 30: 1783
  • Tolman E. L., Fuller B. L., Marinan B. A., Capetola R. J., Levinson S. L., Rosenthale M. E. Tissue selectivity and variability of effects of acetaminophen on arachidonic acid metabolism. Prostaglandins Leuk. Med. 1983; 12: 347
  • Roth G. J., Soik C. J. Acetylation of -NH2 terminal serine of prostaglandin synthetase by aspirin. J. Biol. Chem. 1978; 253: 3782
  • Siegel M. I., McConnell R. T., Porter N. A., Cuatrecasas P. Arachidonate metabolism via lipoxygenase and 12l-hydroperoxy-5,8,10,14-eicosatetraenoic acid peroxidase sensitive to anti-inflammatory drugs. Proc. Natl. Acad. Sci. U.S.A. 1980; 77: 308
  • Siegel M. I., McConnell R. T., Cuatrecasas P. Aspirin-like drug interferes with arachidonate metabolism by inhibition of the 12-hydroperoxy-5,8,10,14-eicosatetraenoic acid peroxidase activity of the lipoxygenase pathway. Proc. Natl. Acad. Sci., U.S.A. 1979; 76: 3774
  • Siegel M. I., McConnell R. T., Porter N. A., Selph J. L., Truax J. F., Vinegar R., Cuatrcasas P. Aspirin-like drugs inhibit arachidonic acid metabolism via lipoxygenase and cyclo-oxygenase in rat neutrophils from carrageenan pleural exudates. Biochem. Biophys. Res. Commun. 1980; 92: 688
  • Appleton R. A., Brown K. Conformational requirements at the prostaglandin cyclooxygenase receptor – site template for designing non-steroidal anti-inflammatory drugs. Prostaglandins 1979; 18: 29
  • Hamberg M. Biosynthesis of prostaglandins in renal medulla of rabbit. FEBS Lett. 1969; 5: 127
  • Porter N. A., Wolf R. A., Weenen H. The free radical oxidation of polyunsaturated lecithins. Lipids 1980; 15: 163
  • Bray M. A. The pharmacology and pathophysiology of leukotriene B4. Br. Med. Bull. 1983; 39: 249
  • Lands W. E. M., Samuelsson B. Phospholipid precursors of prostaglandins. Biochim. Biophys. Acta 1968; 164: 426
  • Kappus H., Sies H. Toxic drug effects associated with oxygen metabolism: redox cycling and lipid peroxidation. Experientia 1981; 37: 1233
  • Hemler M. E., Cook H. W., Lands W. E. M. Prostaglandin biosynthesis can be triggered by lipid peroxides. Arch. Biochem. Biophys. 1979; 193: 340
  • Fujimoto Y., Fujita T. Effects of lipid peroxidation on prostaglandin syntheses in rabbit kidney medulla slices. Biochim. Biophys. Acta 1982; 710: 82
  • Fujimoto Y., Tanioka H., Keshi I., Fujita T. The interaction between lipid peroxidation and prostaglandin synthesis in rabbit kidney-medulla slices. Biochem. J. 1983; 212: 167
  • Egan R. W., Paxton J., Kuehl F. A., Jr. Mechanisms for irreversible self-deactivation of prostaglandin synthetase. J. Biol. Chem. 1976; 251: 7329
  • Shier W. T. Cytolytic mechanisms: self-destruction of mammalian cells by activation of endogenous hydrolytic enzymes. J. Toxicol. Toxin Rev. 1982; 1: 1
  • Cavallo T. Fine structural localization of endogenous peroxidase activity in inner medullary interstitial cells of the rat kidney. Lab. Invest. 1974; 31: 458
  • DeWitt D. L., Rollins T. E., Day J. S., Gauger J. A., Smith W. L. Orientation of the active site and antigenic determinants of prostaglandin endoperoxide synthase in the endoplasmic reticulum. J. Biol. Chem. 1981; 256: 10375
  • Rollins T. E., Smith W. L. Sub-cellular localization of prostaglandin-forming cyclooxygenase in Swiss mouse 3T3 fibroblasts by electron microscopic immunocytochemistry. J. Biol. Chem. 1980; 255: 4872
  • Arnold L., Collins C., Starmer G. A. Renal and gastric lesions after phenylbutazone and indomethacin in the rat. Pathology 1974; 6: 303
  • Lasker J. M., Sivarajah K., Mason R. P., Kalyanaraman B., Abou-Donia M. B., Eling T. E. A free radical mechanism of prostaglandin synthase-dependent aminopyrine demethylation. J. Biol. Chem. 1981; 256: 7764
  • Mizuno K., Yamamoto S., Lands W. E. M. Effects of non-steroidal anti-inflammatory drugs on fatty acid cyclooxygenase and prostaglandin hydroperoxidase activities. Prostaglandins 1982; 23: 743
  • Rahimtula A., O'Brien P. J. The possible involvement of singlet oxygen in prostaglandin biosynthesis. Biochem. Biophys. Res. Commun. 1976; 70: 893
  • Gardner H. W., Crawford C. G., MacGregor J. T. Negative Ames tests of epoxide fatty methyl esters derived from homolysis of linoleic acid hydroperoxides. Food Chem. Toxicol. 1983; 21: 175
  • Kalyanaraman B., Sivarajah K., Eling T. E., Mason R. P. A free radical mediated cooxidation of tetramethylhydrazine by prostaglandin hydroperoxidase. Carcinogenesis 1983; 4: 1341
  • Belvedere G., Tursi F., Elovaara E., Vainio H. Styrene oxidation to styrene oxide coupled with arachidonic acid oxidation by soybean lipoxygenase. Toxicol. Lett. 1983; 18: 39
  • Robertson I. G. C., Sivarajah K., Eling T. E., Zeiger E. Activation of some aromatic amines to mutagenic products by prostaglandin endoperoxide synthetase. Cancer Res. 1983; 43: 476
  • Rapp N. S., Zenser T. V., Brown W. W., Davis B. B. Metabolism of benzidine by a prostaglandin-mediated process in renal inner medullary slices. J. Pharmacol. Exp. Ther. 1980; 215: 401
  • Cohen S. M., Zenser T. V., Murasaki G., Fukushima S., Mattammal M. B., Rapp N. S., Davis B. B. Aspirin inhibition of N-[4-(5-nitro-2-furyl)-2-thiazolyl] formamide-induced lesions of the urinary bladder correlated with inhibition of metabolism by bladder prostaglandin endoperoxide synthetase. Cancer Res. 1981; 41: 3355
  • Adriaenssens P. I., Sivarajah K., Boorman G. A., Eling T. E., Anderson M. W. Effect of aspirin and indomethacin on the formation of benzo(a)pyrene-induced pulmonary adenomas and DNA adducts in A/HeJ mice. Cancer Res. 1983; 43: 4762
  • Cove-Smith J. R., Knapp M. S. Sodium handling in analgesic nephropathy. Lancet 1984; 2: 70
  • Kasenen A., Nanto V., Lehtonen A. Urinary acid mucopolysaccharides in renal patients with and without abuse of phenacetin containing analgesics. Ann. Med. Intern. Fenn. 1964; 53: 33
  • Nanto V., Kasenen A., Lehtonen A. Urinary excretion of amino acids and acid mucopolysaccharides in rats during phenacetin feeding. Ann. Med. Exp. Fenn. 1964; 42: 88
  • Weldrake J. F. The effect of aspirin (acetyl salicylate) on macromolecule turnover in rat kidney and liver. Experientia 1975; 31: 559
  • Risdon R. A. Reflux nephropathy. Diagn. Histopathol. 1981; 4: 61
  • Kincaid-Smith P. Analgesic abuse and the kidney. Kidney Int. 1980; 17: 250
  • Murphy K. J. Calcification of the renal papillae as a sign of analgesic nephropathy. Clin. Radiol. 1968; 19: 394
  • Adriano S. M., Schwarz J. Experimental moniliasis in mice. Am. J. Pathol. 1955; 31: 859
  • Hurley R., Winner H. I. Experimental renal moniliasis in the mouse. J. Pathol. Bacteriol. 1963; 86: 75
  • Knepshield J. H., Feller H. A., Leb D. E. Papillary necrosis due toCandida albicans in a renal allograft. Arch. Intern. Med. 1968; 122: 441
  • Tomashefski J. F., Abramowsky C. R. Candida-associated renal papillary necrosis. Am. J. Clin. Pathol. 1981; 75: 190
  • Pigman W., Rizvi S., Holley H. L. Depolymerization of hyaluronic acid by the ORD reaction. Arthritis Rheum. 1961; 4: 240
  • Matsumura G., Pigman W. Catalytic role of copper and iron ions in the depolymerization of hyaluronic acid by ascorbic acid. Arch. Biochem. Biophys. 1965; 110: 526
  • Matsumura G., Herp A., Pigman W. Depolymerization of hyaluronic acid by autoxidants and radiations. Radiat. Res. 1966; 28: 735
  • Halliwell B. Superoxide-dependent formation of hydroxyl radicals in the presence of iron salts. FEBS Lett. 1978; 96: 238
  • Halliwell B. Superoxide-dependent formation of hydroxyl radicals in the presence of iron chelates. Is it a mechanism for hydroxyl radical production in biochemical systems. FEBS Lett. 1978; 92: 321
  • Greenwald R. A., Moy W. W. Effect of oxygen-derived free radicals on hyaluronic acid. Arthritis Rheum. 1980; 23: 455
  • Puig-Parellada P., Planas J. M. Synovial fluid degradation induced by free radicals.In vitro action of several free radical scavengers and anti-inflammatory drugs. Biochem. Pharmacol. 1978; 27: 535
  • Betts W. H., Cleland L. G. Effect of metal chelators and antiinflammatory drugs on the degradation of hyaluronic acid. Arthritis Rheum. 1982; 25: 1469
  • Bailey R. R., McRae C. U., Maling T. M. J., Tisch G., Little P. J. Renal vein renin concentration in the hypertension of unilateral reflex nephrology. J. Urol. 1978; 120: 21
  • Bengtsson U. Long-term pattern in chronic pyelonephritis. Contrib. Nephrol. 1979; 16: 31
  • Susic D., Kentera D. Role of the renal medulla in the resistance of rats to salt hypertension. Pfluegers Arch. 1980; 384: 283
  • Nanra R. A. 1983, unpublished data

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.